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Few other aspects of food supply and metabolism are of greater biological importance than the 
feeding of mothers during pregnancy and lactation, and of their infants and young children. 
Nutritional factors during early development not only have short-term effects on growth, body 
composition and body functions but also exert long-term effects on health, disease and mortality 
risks in adulthood, as well as development of neural functions and behaviour, a phenomenon 
called ‘metabolic programming’. The interaction of nutrients and gene expression may form the 
basis of many of these programming effects and needs to be investigated in more detail. The 
relation between availability of food ingredients and cell and tissue differentiation and its 
possible uses for promoting health and development requires further exploration. The course of 
pregnancy, childbirth and lactation as well as human milk composition and the short- and long- 
term outcome of the child are influenced by the intake of foods and particularly micronutrients, 
e.g. polyunsaturated fatty acids, Fe, Zn and I. Folic acid supplementation from before conception 
through the first weeks of pregnancy can markedly reduce the occurrence of severe embryonic 
malformations; other potential benefits of modulating nutrient supply on maternal and child 
health should be further evaluated. The evaluation of dietary effects on child growth requires 
epidemiological and field studies as well as evaluation of specific cell and tissue growth. Novel 
substrates, growth factors and conditionally essential nutrients (e.g. growth factors, amino acids, 
polyunsaturated fatty acids) may be potentially useful as ingredients in functional foods and need 
to be assessed carefully. Intestinal growth, maturation, and adaptation as well as long-term 
function may be influenced by food ingredients such as oligosaccharides, gangliosides, high- 
molecular-mass glycoproteins, bile salt-activated lipase, pre- and probiotics. There are indica- 
tions for some beneficial effects of functional foods on the developing immune response, for 
example induced by antioxidant vitamins, trace elements, fatty acids, arginine, nucleotides, and 
altered antigen contents in infant foods. Peak bone mass at the end of adolescence can be 
increased by dietary means, which is expected to be of long-term importance for the prevention of 
osteoporosis at older ages. Future studies should be directed to the combined effects of Ca and 
other constituents of growing bone, such as P, Mg and Zn, as well as vitamins D and K, and the 
trace elements F and B. Pregnancy and the first postnatal months are critical time periods for the 
growth and development of the human nervous system, processes for which adequate substrate 
supplies are essential. Early diet seems to have long-term effects on sensory and cognitive 
abilities as well as behaviour. The potential beneficial effects of a balanced supply of nutrients 
such as I, Fe, Zn and polyunsaturated fatty acids should be further evaluated. Possible long-term 
effects of early exposure to tastes and flavours on later food choice preferences may have a major 
impact on public health and need to be further elucidated. The use of biotechnology and 
recombinant techniques may offer the opportunity to include various bioactive substances in 
special dietary products, such as human milk proteins, peptides, growth factors, which may have 
beneficial physiological effects, particularly in infancy and early childhood. 
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1. Introduction 
There are few other aspects of food supply and the meta- 
bolism of food ingredients that are of greater biological 
importance than the feeding of mothers during pregnancy 
and lactation, and of their children. The rapid growth of 
fetuses, infants and children, which double their body 
weights within only 6 weeks in utero and 4-5 months 
after birth respectively, depends on the supply of very 
large amounts of nutrients per kg body weight through the 
placenta, human milk and children's diets. Marginal nutri- 
ent supplies are usually more critical in a developing and 
growing organism than in steady-state situations during 
adulthood. The ability to effectively utilize and compensate 
for unbalanced supplies is severely limited in the fetus and 
in young children due to small endogenous stores of a 
number of relevant substrates, and in many cases also due 
to immature metabolic pathways (e.g. amino acid metabol- 
ism) and physiological functions (e.g. renal conservation of 
substrates). Nutritional factors during early development 
have important immediate and short-term effects on growth, 
body composition and body functions. In addition, accumu- 
lating data indicate long-term effects of nutritional and 
metabolic factors during critical time periods of develop- 
ment on later physiological and metabolic processes, a 
phenomenon referred to as 'metabolic programming' 
(Barker, 1994). For example, epidemiological studies have 
suggested long-term effects of intrauterine and postnatal 
nutrient supply on the prevalence of obesity in adulthood 
(Ravelli et al. 1976) and on the risk of developing diabetes, 
hypertension, hypercholesterolaemia, CHD, and other dis- 
orders during adult life (Barker, 1994). The rate of death 
from all cardiovascular disease and from CHD (Fig. 1) in 
adulthood was found to be significantly related to body 
weight at birth (Osmond et al. 1993; Barker, 1994). Stan- 
dardized mortality from CHD was also closely related to 
weight at 1 year in males but not in females (Fig. 2). These 
findings indicate the potential of influencing long-term 
health and life expectancy by modulations of maternal 
diet in pregnancy and of postnatal infant feeding. Moreover, 
the type of postnatal infant feeding has been related to long- 
term outcomes such as the later incidence of insulin-depen- 
dent diabetes mellitus (IDDM) (Virtanen et al. 1991; 
Gerstein, 1994) and cognitive development (Lucas et al. 
1992; Lanting et al. 1994), and a lasting effect of Ca intake 
during childhood and adolescence on bone mineral density 
and the risk of fractures in old age has been proposed (Ribot 
et aZ. 1995). This programming of permanent effects of the 
physiology and function of the organism during critical time 
periods of early development appears to be of major 
importance in preventive health strategies. Improved 
knowledge on the cellular and molecular mechanisms of 
programming and of the complex physiological and 
nutritional factors relevant to the health and well-being 
during the periods of reproduction and childhood is 
required. A better definition of the optimal supply of 
relevant nutrients and other food ingredients is expected 
to help optimize dietary intakes during these critical periods 
of life which should improve the chances that infants and 
children have to utilize fully their genetic potential, as well 
as maintain maternal health. 
2. Nutrient-gene interaction, genetic regulation 
2. I .  Introduction 
The perinatal period is attended by important modifications 
in energy metabolism (Girard et al. 1992). In utero, the fetus 
receives a continuous intravenous supply of substrates for 
growth and oxidative metabolism. Immediately after birth, 
the maternal supply of substrates ceases abruptly and the 
newborn has to withstand a brief period of starvation before 
being fed at intervals with milk, a high-fat and low-carbo- 
hydrate diet. The sucking-weaning transition is also char- 
acterized by profound changes of nutrition (Girard et al. 
1992). Towards the end of the sucking period, the milk is 
progressively replaced by the solid food diet of the adult, the 
composition of which is usually lower in fat and higher in 
carbohydrates. The successful adaptation of neonates to 





















15.5 16.5 17.5 18.5 59.5 >9.5 
Birth weight (British pounds) 
Fig. 1. Standardized mortality ratios for CHD below age 65 years, showing a statistically significant relationship with birth weight in 5585 women 
and 10 141 men born between 191 1 and 1930. (Data from Barker, 1994.) 
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Fig. 2. Standardized mortality ratios for CHD below age 65 years, showing a statistically significant relationship with weight at age 1 year in 10 141 
men, but not in 5585 women born between 191 1 and 1930. (Data from Barker, 1994.) 
of energy metabolism in the vast majority of organs, 
intestine, liver, muscle, adipose tissue and brain. Postnatal 
development is also associated with differentiation pro- 
cesses and a high growth rate, involving specific require- 
ments of nutrients such as amino acids (protein synthesis) or 
fatty acids (e.g. brain growth). Thus, nutrients can be 
considered to cause energy metabolism modifications but 
also to play a major role in organ growth and/or functional 
differentiation. 
2.2. Modulation of gene expression participates in the 
adaptations of energy metabolism 
The adaptations of energy metabolism to the nutritional 
environment imply the modulation and/or emergence of 
metabolic pathways. This can be achieved through changes 
in the efficiency of a given step (specific transporters, 
enzymes) by allosteric or phosphorylation-dephosphoryla- 
tion mechanisms, or by translocation of a protein into a 
different cellular compartment. However, many of these 
adaptations also imply a change in the amount of a given 
protein. This phenomenon is usually related to a change of 
the transcription rate of the corresponding gene. 
A good example of such a mechanism is the appearance at 
birth in mammals of phosphoenolpyruvate carboxykinase 
(EC 4.1.1.49), an enzyme of the gluconeogenic pathway 
allowing the de novo production of glucose by the liver 
(Girard et al. 1992). This pathway is essential for the 
survival of the newborn mammal, which undergoes a brief 
period of starvation followed by the ingestion of a diet low 
in carbohydrates, the milk. The transcription rate of this 
gene is extremely low during the fetal period and increases 
abruptly in the first hours after birth, allowing the newborn 
to maintain glucose homeostasis. 
Another example is the lipogenic pathway in the rat 
species. This pathway allows synthesis of fatty acids from 
glucose when this substrate is ingested in excess of energy 
requirements. During the sucking period, the capacity of 
this pathway is kept very low because the small quantity 
of glucose ingested is essentially directed towards 
oxidative processes. When the rat is weaned onto the 
high-carbohydrate diet, this pathway is switched on and 
excess glucose will be converted into fatty acids, ultimately 
stored as triacylglycerols in the adipose tissue. The expres- 
sion of one of the key enzymes of this pathway, fatty acid 
synthase (EC 2.3.1.85) is extremely low during the sucking 
period but increases when the rat is weaned onto the adult 
high-carbohydrate diet, but not if weaning occurs onto a 
high-fat diet, clearly underlining the importance of the 
nutritional environment in this process. This phenomenon 
is due to the activation of the gene transcription process at 
weaning (Foufelle et al. 1996). Thus, modulation of gene 
expression must be considered as an integral part of the 
adaptations occumng during development. 
Although it has been known for a long time that nutrients 
can regulate the expression of specific genes in prokaryotes 
(the lactose operon in Escherichia coli for instance) or in 
primitive eukaryotes such as yeasts, the demonstration that a 
similar phenomenon occurs in higher eukaryotes is recent. 
The regulation of specific gene expression in mammals in 
response to changes in nutrition has become a major aspect 
of modem nutrition, due to the emergence of molecular 
biology that has allowed the cloning of most of the genes 
involved in the regulation of energy metabolism. Recently, 
it has been demonstrated that major (glucose, fatty acids, 
amino acids) or minor (Fe, vitamins) dietary constituents 
participate, in concert with hormones, in the regulation of 
gene expression in response to nutritional changes (see for 
instance Clarke & Abraham, 1992). 
2.3. Examples of gene regulation by nutrients 
2.3.1. Carbohydrates. In the liver and adipose tissue, 
excess glucose, after its metabolism into pyruvate through 
glycolysis is converted into fatty acids by the lipogenic 
pathway. The expression of three enzymes of the combined 
glycolytic-lipogenic pathway has been shown to respond to 
an increased glucose concentration: L-pyruvate kinase (EC 
2.7.1.40; liver), fatty acid synthase and acetyl-coA car- 
boxylase (EC 6.4.1.2; liver and adipose tissue) (Foufelle et 
al. 1992; Vaulont & Kahn, 1994). In vivo, it has been shown 
in rats that high-carbohydrate diets induce the transcription 
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of these genes, whereas transcription is inhibited by starvation 
or a high-fat diet. During the sucking period in rats, the 
expression of these enzymes is kept low and dramatically 
increases at weaning on to a high-carbohydrate diet. In vitro 
studies have shown that glucose is the primary inducer of the 
gene transcription. This effect requires that glucose is 
metabolized at least into glucose-6-phosphate which might 
be the signal metabolite. The response of transcription to high 
glucose is a very rapid phenomenon (less than 1 h). Glucose 
response elements, which bind specific transcription factors of 
the U S F M T F  family have been characterized on these 
genes although the mechanism linking glucose-6-phosphate to 
transcription factors is presently unknown (Foufelle et al. 
1996). In the @-cells of the islets of Langerhans, glucose 
induces the transcription of the insulin gene on which glucose 
response elements have also been characterized (Docherty & 
Clark, 1994). This feature is obviously relevant to the diabetic 
syndrome. 
2.3.2. Fatty acids. In vitro studies have shown that the 
transcription of a number of genes of adipocytes is increased 
in the presence of fatty acids. This is the case, for 
instance, for phosphoenolpyruvate carboxykinase, an 
enzyme involved in this tissue in the provision of 
a-glycerophosphate necessary for the esterification of 
fatty acids (Antras-Ferry et al. 1995). Similarly, the 
expression of the fatty acid binding protein ap2, which 
binds fatty acids into the cell, is strongly stimulated by fatty 
acids (Grimaldi et al. 1992). Fatty acid response elements 
have been characterized in the promoter of these genes. 
They bind a transcription factor called peroxisome prolif- 
erator activated receptors (PPAR) which can be activated by 
the binding of fatty acids or a metabolite of fatty acids 
(prostaglandin for instance) (Schoonjans et al. 1996). 
Fatty acids have also been shown to inhibit gene expres- 
sion in rats. The addition of a small amount (20-30 g k g )  of 
polyunsaturated fatty acids (PUFA) of the n-3 or n-6 
families to a high-carbohydrate fat-free diet decreases 
markedly the lipogenic capacity and the activity of lipo- 
genic enzymes (Clarke, 1994). In contrast, monounsaturated 
and saturated fatty acids have no effects. Interestingly 
enough, this effect seems to be specific to the liver since 
lipogenesis is not affected in the adipose tissue. The 
decrease induced by PUFA of the activity of lipogenic 
enzymes such as fatty acid synthase, acetyl-CoA carboxy- 
lase or glucose-6-phosphate dehydrogenase (EC 1.1.1.49), 
is clearly linked to an inhibition of gene transcription 
as shown in studies using primary cultures of rat hepato- 
cytes (Clarke, 1994). At the present time the cellular and 
molecular mechanisms involved in the inhibitory effect of 
PUFA on gene transcription have not been elucidated. 
2.2.3. Cholesterol. A very interesting series of studies 
has been performed by the group of Brown and Goldstein on 
the effect of cholesterol on gene expression (Wang et al. 
1994). Cholesterol represses the expression of genes 
involved either in the synthesis of cholesterol (cytoplasmic 
hydroxymethylglutaryl-CoA synthase, EC 4.1.3.5) or in its 
uptake from external sources, the LDL receptor (LDL are 
lipoproteins rich in cholesterol). In the absence of 
cholesterol, the transcription of these genes is activated by 
a transcription factor called sterol regulatory element 
binding protein (SREBP). SREBP is usually hooked onto 
the endoplasmic reticulum where it can be cleaved by a 
protease. SREBP can then be transferred into the nucleus 
and activates the transcription of relevant genes. In the 
presence of cholesterol, the protease is inhibited and SREBP 
can no longer enter into the nucleus and stimulate gene 
transcription (see Fig. 3). 
2.3.4. Amino acids. In yeast, amino acid starvation 
results in the activation of several genes involved in N 
metabolism and the mechanisms involved are now known 
(Kilberg et al. 1994). In mammalian cells, amino acid 
availability also modulates the expression of some genes as 
shown, for instance, for asparagine synthetase (EC 6.3.5.4) 
which is responsible for the biosynthesis of asparagine from 
aspartate and glutamine. When cultured cells are transferred 
to a medium lacking asparagine, the concentration of 
asparagine synthetase mRNA increases. It must be under- 
lined, however, that the signalling mechanism exhibits a 
broad substrate specificity since availability of other 




STEROL RESPONSE ELEMENT 
Fig. 3. Model for the cholesterol-dependent control of gene transcription. SREBP, sterol regulatory element binding protein. 
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concentration as well. The mechanisms for the increase in 
asparagine synthetase mRNA concentration could involve 
both cis-acting elements contained in the mRNA itself and 
affecting its stability, as well as in the genomic promoter 
sequence (Kilberg et al. 1994). The signal metabolite could 
be, in fact, the degree of occupancy of the transfer RNA as 
in yeast, although evidence is clearly lacking. 
2.4. Nutrients and cell differentiation 
The fetal-neonatal period is also characterized by the 
differentiation of a number of organs. One important ques- 
tion, which is presently totally unaddressed, is whether 
nutrients could affect differentiation per se and thus 
modulate physiological functions on a long-term basis. 
Two examples are listed here. 
2.4.1. Fatty acids. One example of such a mechanism 
stems from in vitro studies on pre-adipocyte cell lines. It has 
been shown that fatty acids are not only able to modulate the 
transcription rate of specific genes in differentiated 
adipocytes, but are also able to induce preadipocyte 
differentiation into adipocytes through their action on a 
specific isofonn of a PPAR transcription factor (Schoonjans 
et al. 1996). Obviously, if this happens also in vivo, it would 
imply that perinatal nutrition could modulate the number of 
adipocytes and, thus, be a crucial determinant of a possible 
expansion of this tissue, in relation to the obesity syndrome. 
2.4.2. Retinoic acid. Vitamin A or retinol can be 
oxidized to retinoic acid in cells. In addition to retinol, 
P-carotene may also be a source of retinoic acid. Retinoic 
acid and retinoid X receptors which belong to the family of 
steroid-thyroid hormone receptors have been cloned (De 
Luca, 1991). They are, in fact, ligand-activated transcription 
factors (of the same family as the PPAR, see p.S9). It has 
been shown in numerous studies that retinoic acid is a potent 
morphogen and that it can affect fetal development (De 
Luca, 1991). Thus, vitamin A or P-carotene deficiency or 
overload might have major consequences on tissue 
differentiation and fetal development. 
2.5. Concluding remarks 
These examples underline the idea that gene regulation by 
nutrients, a process we induce each time we eat a food of 
specific composition, includes a very wide range of mechan- 
isms involved in the regulation of crucial pathways as well 
as in cell differentiation. Since the fetal-neonatal period 
is concomitant with marked changes in the nutritional 
environment, it represents a period in which these 
mechanisms are particularly important. 
As for other components of cell functions, it is very likely 
that gene regulation by nutrients is subject to variations 
linked to genetic polymorphisms among individuals, of 
which some could ultimately lead to pathologies. This 
obviously opens new fields for genetic studies on nutrient- 
related pathologies (obesity, for instance). 
3. An overview of programmed cell death (apoptosis) 
A type of cell death which does not involve primary cell 
membrane disintegration and tissue inflammatory responses 
was identified some 70 years ago, and the term apoptosis 
was applied by analogy with the deciduous loss of leaves by 
trees. The process was identified by characteristic histo- 
morphological changes in the cell nuclei (Kroemer et al. 
1995). Although apoptosis is sometimes used as a synonym 
for programmed cell death (PCD), it has become apparent 
that apoptosis can be caused by noxious or toxic events 
which might affect several cell components and not just 
primarily the nucleus. PCD applies to the entire process and 
phenomenology of this form of cell death and thus embraces 
the intrinsic mechanisms and regulatory processes involved. 
PCD might not necessarily be induced by external toxic 
stimuli, but rather by signals which are a fundamental 
component of cellular and tissue physiology. The distinction 
between the two terms PCD and apoptosis is subtle, and not 
invariably respected. Clearly it is misleading to characterize 
PCD on the basis of nuclear morphological changes since 
these are not always the primary events in PCD (Kroemer et 
al. 1995; Hale et al. 1996; Vaux & Strasser, 1996; Nagata, 
1997) but one should not be distracted overmuch by the 
distinction: rather interest should focus on the processes 
involved in the induction, mediation, regulation and process 
of the cellular events, and the ways in which dietary compo- 
nents might affect these mechanisms which are fundamental 
to tissue differentiation, development and function. 
PCD is a more appropriate description of a variety of 
intrinsic cellular events, involving cytoplasmic as well as 
nuclear processes which precede loss of intracellular and 
cellular membrane integrity, should these occur at all. 
However, non-physiological stimuli can effect mechanisms 
involved with PCD, and the process or its dysfunction can 
be an integral part of oncogenesis and autoimmune dis- 
orders (Hale et aE. 1996). 
All multicellular organisms use PCD to remove super- 
fluous and damaged cells in tissues and organs, particularly, 
but not exclusively, in proliferating tissues. There is a strong 
evolutionary conservation of the mechanisms of PCD and 
the nematode Caenorhabditis elegans is a valuable model 
for the system in higher species, including man, in whom 
several genes and effectors of PCD are homologous to cell 
death genes and products in C. elegans (e.g. proto-oncogene 
bcl-2 is homologous to the nematode ‘cell-suicide gene’ 
ced3) (Kroemer et al. 1995; Vaux & Strasser, 1996). 
The induction mechanisms of PCD are more complex in 
higher animals in whom co-operativity between the differ- 
ent tissues of organs plays an important part in determining 
PCD. For example, the extracellular matrix exerts some 
control over differentiation and morphogenesis of organs by 
specific effects on constituent cells, tissue-specific gene 
expression, and cell death (Roskelley et al. 1995). This is 
important for the differentiation of tissues and organs (e.g. 
the gastrointestinal tract) throughout life as well as during 
embryogenesis. 
PCD can be envisaged to comprise three stages: induc- 
tion, the effector stage, and degradation (Fig. 4) (Kroemer et 
al. 1995). There are at least two principal routes of inducing 
PCD. One involves genotoxic events damaging DNA; the 
other involves receptor-mediated stimuli such as specific 
death signals, the absence of rescue signals such as growth 
factors, and contradictory or conflicting signals (Kroemer et 
al. 1995; Nagata, 1997). 
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progressing to degradation 
Fig. 4. The stages of programmed cell death and apoptosis. (From Kroemer et al. 1995.) 
The origin of signals can be systemic or local (e.g. 
extracellular matrix) (Hakomori & Igarashi, 1995) humoral 
cytokines (Nagata, 1997), or cellular such as cytotoxic T 
cells. The signal and transduction systems stimulating PCD 
include steroids (Evans-Storms & Cidlowski, 1995), cyto- 
kines such as tumour necrosis factor and nerve growth factor 
and interleukins, all of which operate through their cognate 
receptors (Cosman, 1994; Nagata, 1997). 
The responsiveness to such stimuli may also be deter- 
mined by the nature of the cell surface receptors which 
might change during ontogenesis (and, for that matter, 
oncogenesis). The surface receptors include glycosphingo- 
lipids, lectins and sphingosines and their respective roles 
have not been totally clarified. It is noteworthy that inherited 
defects of cell-surface CD40 cause a human X-linked 
immunodeficiency syndrome associated with defective 
PCD, and analogous syndromes in mice are associated 
with congenital abnormalities of Fas receptors and ligands 
(Cosman, 1994; Nagata, 1997). Changes in structural com- 
ponents of cellular membranes (e.g. ceramide formation) 
can induce signal transduction cascades (Ballou et al. 1996) 
leading to cell death. 
The heterogeneity of signals is matched by the variety of 
effector mechanisms which are stimulated. These involve 
tyrosine kinase, protein kinase C, and other kinases, Ca 
permeability routes and intracellular proteases. These initi- 
ate an amplification cascade affecting a number of genes, 
several of which are known proto-oncogenes (e.g. c-myc) or 
tumour suppressors (e.g. p53) and which are common both 
to PCD and to the regulation of normal cell differentiation, 
function and intermediate metabolism (Kroemer et al. 1995; 
Hale et al. 1996; Nagata, 1997). This highlights the central 
conundrum of PCD, namely what is the ultimate determin- 
ant of whether a cell undergoes PCD or not? Is there a 
threshold event? It has been suggested that one basic 
determinant is the stage of the cell cycle when the cell 
receives the relevant signals (Meikrantz & Schlegel, 1995) 
or the availability of an appropriate nutrient supply (that is, 
do some stressors such as a specific nutrient excess or 
deficiency induce cell death by more direct means than, 
say, oxidant damage or simple starvation?). 
Intrinsic effector systems for cell death programmes 
involve cytoplasmic and nuclear metabolic and functional 
disintegration with ultimate morphological damage. Within 
the mitochondria there is a decrease in transmembrane 
potential, energy uncoupling of the respiratory chain, and 
increased production of reactive 0 species. These increase 
oxidative damage and increase leakage of mitochondria1 Ca. 
In the cytoplasm there is a loss of anabolic activities with a 
corresponding activation of proteases, disruption of the 
cytoskeleton and of the endoplasmic reticulum: similarly 
in the nucleus the endonucleases are activated and there is 
nucleolysis with some activation of enzymes usually asso- 
ciated with repair activity. 
The mechanisms and regulation of PCD and apoptosis in 
abnormal cell proliferation have focused on their role in 
cancer and the possibility that external events or compounds 
might induce, suppress, regress, or protect against cancer by 
affecting these processes. The potential role of dietary 
components influencing these processes is being invest- 
igated actively in relation to functional food science. In 
other physiological areas there might exist other opportu- 
nities to explore and exploit a better understanding of these 
processes in cellular proliferation and differentiation. These 
are outlined in the following paragraphs. 
PCD of uterine cells enables blastocyst implantation and 
placentation (Welsh, 1993). Prostaglandins, leukotrienes, 
platelet-activating factor, and transforming growth factor 
are thought to induce this process. In embryogenesis there is 
extensive mesodermal PCD to eliminate undifferentiated 
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cells (Sanders & Wride, 1995; Wride & Sanders, 1995). The 
extracellular matrix and the regulation of cell adhesion 
molecules and integrins, perhaps involving tumour necrosis 
factor-a as a cellular growth and differentiation factor, have 
been shown in the regulatory processes in the morphogen- 
esis of the limb bud (Hurle et al. 1995). 
Again extracellular matrix and specified cell adhesion 
molecules control endothelial cell position and behaviour 
and enable the definition of mechanisms directing endothe- 
lial cell differentiation, commitment, migration and organ- 
ization into a tube as the fundamental components of 
vasculogenesis (Baldwin, 1996). PCD has also been 
shown to be integral to the development of the conduction 
processes and to be involved in the pathogenesis of 
congenital cardiac structural and electrical conduction 
abnormalities as well as acquired cardiovascular disease 
(James, 1993). The role of PCD in intestinal mucosal 
development and differentiation is discussed elsewhere: a 
similar dependence on PCD has been demonstrated in renal 
organogenesis (Igarashi, 1994). 
It is in haematopoiesis and in the development of the 
immune system that there might be some particular aspects 
of relevance to functional food science. Haematopoiesis and 
PCD involve an extensive multigene cytolune network 
which has positive regulators such as colony-stimulating 
factors and interleukins and negative regulators such as 
transforming growth factor-/3 and tumour necrosis factor 
(Krammer et al. 1994; Cidlowski et al. 1996; Sachs, 1996). 
Apoptosis in T and B lymphocytes is involved in all 
fundamental processes in the immune system and PCD 
appears to be vital in selecting or favouring development 
of specific lymphocytes and eliminating cells which are 
sensitized to autoantigens. Factors which would interfere 
with this process would be undesirable and there exists a 
possibility that similar selective processes might underlie 
the acquisition of immunotolerance to ingested antigens in 
foods or the development of adverse immune reactions to 
food constituents. 
In the central nervous system neurones and glia synthesize 
and secrete cytokines which affect the differentiation and 
function of nerve cells (Dragunow & Preston, 1995; Kawata, 
1995; Sei et al. 1995). Disturbance of these cytokine- 
mediated interactions may lead to neuronal dysfunction 
andor cell death and contribute to the pathogenesis of 
central nervous system diseases. The functional and cellular 
differentiation underlying sexual dimorphism in the central 
nervous system might depend on the effects of steroids on 
PCD in the relevant regions of the brain. 
Many of the phenomena regarded as inevitable 
consequences of ageing, including nerve cell death, involve 
processes of PCD and apoptosis, and a better understanding 
of these events might in due course lead to a more sophist- 
icated and rational scientific basis on which to base 
functional food science and its application to avoid the 
depredations of ageing (Zakeri & Lockshin, 1994). 
4. Supply of food ingredients before and during 
pregnancy 
The nutritional status of the mother before and during 
pregnancy may influence fertility, the course of pregnancy 
and the incidence and severity of complications during 
gestation and birth, lactation (Rasmussen 1992), and the 
short- and long-term health and development of the baby. 
During recent years scientific understanding of the physi- 
ology of energy metabolism, weight gain and particularly 
the effects of micronutrient status and their clinical con- 
sequences have considerably improved. The dietary supply 
of certain nutrients may have beneficial or preventive 
aspects both for the course of gestation and for the offspring. 
4. I .  Physiological aspects of nutritional requirements in 
pregnancy 
The range of weight changes that occurs in pregnant women 
is wide and ranges from a loss of weight to a gain of 25 kg or 
more. A normal weight gain during pregnancy for most 
women with normal prepregnancy weight is in the order of 
11-15 kg (Institute of Medicine, 1990). In addition to food 
intake, weight gain is also influenced by medical disorders 
such as development of oedema associated with pre- 
eclampsia. The weight increase and substrate deposition in 
maternal and fetal tissues is not only due to increased 
dietary intake during pregnancy, but also supported by a 
variety of complex adaptations of gastrointestinal, endo- 
crine and metabolic functions. The effects of food ingredi- 
ents on these adaptations as well as on placental function 
and the efficacy of materno-fetal substrate transfer are not 
well understood and require further exploration. Substrate 
needs during pregnancy are not only met by the food 
consumed during this period of time, but food intake 
before or between pregnancies may be of major importance 
for providing adequate availability of a number of nutrients, 
e.g. Ca and Fe. Also, it is increasingly appreciated that 
substrate needs during pregnancy may show marked inter- 
individual variability, partly due to genetic heterogeneity in 
a population as is the case for metabolic pathways involving 
folic acid. 
4.1.1. Energy. Based on a factorial approach calculat- 
ing the additional energy requirements for the deposition of 
protein and fat as well as the energetic cost of tissue 
synthesis and enhanced maintenance metabolism, the total 
energy cost of pregnancy is assumed to be in the order of 
334.72 MJ (80 000 kcal) (Food and Agriculture Organiza- 
tion/World Health Organizatioflnited Nations University 
(FAOWHONNU), 1985). In women who maintain their 
previous physical activity, this results in an additional 
energy allowance of about 837 kJld (200 kcalld) equivalent 
to an increase of 9 % over the energy needs of 9.2 MJ (2200 
kcal) of a non-pregnant, moderately active woman, or if 
adapted to an estimated increase of energy needs during the 
course of pregnancy, about 628 Wld (150 kcal/d) during the 
first and about 1464 kJ1d (350 kcalld) during the second and 
third trimesters of pregnancy (FAOWHONNU, 1985). 
However, energy needs may be lower with reduced physical 
activity, particularly towards the end of pregnancy. 
While moderately reduced energy intakes have little 
effect on pregnancy outcomes, severe energy deprivation 
during pregnancy results in reduced infantile birth weight. 
During the 6-month period of the Dutch famine with an 
available energy supply below 4184 kJ1d (1000 kcalld) and 
a protein intake of no more than 30-40 gld, average birth 
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weight fell by 200 g (Ravelli et al. 1976). The effect was 
most marked if the hunger period coincided with the latter 
part of pregnancy. Later studies have confirmed these 
observations. In underweight women, a close relationship 
between maternal and neonatal body weights has been 
observed, while the correlation is much less close in 
pregnant women with a normal body weight (Luke & 
Petrie, 1980). Not only total body weight, but also the 
organ weights of liver, spleen, heart, adrenal gland, kidneys, 
skeleton and thymus are reduced in newborn infants of 
mothers who are underweight (Naeye et al. 1969), and 
placental size and number of cells by 15-20 % in pregnancy 
with intrauterine infantile growth failure or even up to 50 % 
in severe maternal malnutrition (Winnick, 1970). In mal- 
nourished South American women, average placental 
weights were reduced by about 15%, and there was a 
marked reduction of the placental peripheral villi surface, 
the site of materno-fetal nutrient transfer, which may 
aggravate the restricted nutrient supply to the fetus in 
malnourished mothers. These findings are of concern, 
since neonatal birth weight is the strongest predictor of 
infant morbidity and mortality, and epidemiological studies 
have found strong associations of low birth weights with 
increased risks for cardiovascular disease and total mortality 
rates in adulthood (Barker, 1994). 
Several studies on energy supplementation during preg- 
nancy in malnourished women found an increase in average 
birth weight and a reduction of the rate of low-birth-weight 
infants (Lechtig et al. 1975; Prentice et al. 1987), while 
intervention studies with an increased energy intake in 
apparently healthy women in Europe did not have signifi- 
cant effects on neonatal weight. However, dietary supple- 
mentation in Canadian women with twin pregnancies 
resulted in an increase of average birth weight by 80 g, 
and reductions of preterm deliveries and the rate of very- 
low-birth-weight infants by 30 and 50 % respectively 
(Dubois et al. 1991). In conclusion, energy supplements 
during pregnancy appear to be beneficial in selected popula- 
tions at risk of very low intakes or increased demands. 
4.1.2. Protein. With a factorial approach again based 
on calculated materno-fetal accretion, the additional 
protein requirements for the four successive 10-week 
periods of a normal pregnancy have been estimated as 0.6, 
1.8, 4.8 and 6.1 g/d, respectively (Hytten & Leitch, 1971), 
and an increase of recommended protein intakes by about 
6 g/d (expressed as milk or egg protein) over non-pregnancy 
values has been recommended (FAO/WHO/UNU, 1985). 
Even though this represents an increase of about 30 % over 
recommended intakes in non-pregnant women, and hence 
the recommended relative increment of protein intake is 
clearly higher than that of energy, the protein intakes of 
most pregnant women in Europe tend to exceed minimal 
requirements by far, with the possible exception of small 
subgroups consuming low-protein diets. It has been 
proposed that protein-enriched diets during pregnancy 
may be beneficial for the prevention of pregnancy-induced 
hypertension and pre-eclampsia, but conclusive evidence to 
support these hypotheses is missing (Roberts et al. 1974; 
Williams et al. 1981). 
4.1.3. Carbohydrates. Glucose serves as the major 
energy source for the fetus, comprising about 90% of the 
energy supply. Hence, maternal carbohydrate metabolism 
during gestation is of potential relevance to the optimal 
supply for the fetus. Little is known about the effects of 
dietary habits, particularly the total amount and relative 
composition of sugars and starches on gestation, and 
potential implications for clinically relevant outcome 
variables such as macrosomia, postpartal hypoglycaemia, 
or increased risk of developing glucose intolerance later in 
life. 
4.1.4. Lipids. Although there is a tendency in some 
pregnant women to aim at a low consumption of dietary fat 
(Hachey, 1994), there are no conclusive data to demonstrate 
the safety of maternal low-fat diets or immediate benefits for 
pregnant women and the fetus and infant. On the other hand, 
pregnant women appear to have high requirements for lipid- 
soluble vitamins and PUFA. During pregnancy, the 
concentrations of blood lipids and their constituent fatty 
acids increase considerably. Amounts (mg/l) of plasma 
phospholipid-associated essential fatty acids (EFA) were 
reported to increase during the course of pregnancy by about 
40% and those of the long-chain PUFA arachidonic acid 
(20:4n-6) and docosahexaenoic acid (DHA, 22:6n-3) by 
about 23 and 52 % respectively (A1 et al. 1995). It has been 
proposed that a high supply of long-chain n-3 fatty acids 
may be beneficial for fetal development because of the 
importance of these compounds for neural tissue develop- 
ment (Koletzko, 1992), and that they may improve some 
obstetric complications, particularly lessen the severity of 
pregnancy-induced hypertension (Secher & Olsen, 1990). 
Moreover, observations in the population of the Faroe 
islands which consumes a diet rich in fish suggested that this 
high intake of n-3 fatty acids may increase average birth 
weight by prolonging gestation (Olsen et al. 1986). 
However, in this population there were also apparent 
adverse effects of n-3 fatty acids, including higher rates of 
blood loss on delivery, which may be explained by fish-oil- 
induced suppression of platelet aggregation, and a higher 
perinatal mortality. An intervention with supplementation 
of n-3 long-chain PUFA was reported to prolong pregnancy 
without any detrimental effects on growth of the fetus or the 
course of delivery (Olsen et al. 1992). Supplementation of 
fish oil with vitamins and minerals has been considered to 
reduce the frequency of pre-eclampsia, but a double-blind 
placebo-controlled trial did not find any effect of fish-oil 
supplementation on the occurrence of pregnancy-induced 
hypertension (Onwude et al. 1995). 
Pregnancy may be associated with DHA mobilization 
from maternal stores. Under the present dietary conditions, 
pregnancy is associated with a reduction of the EFA status 
and particularly of the DHA status. After delivery normal- 
ization takes place, but recovery of the DHA status appears 
to be still incomplete after 6 months (Al et al. 1995). 
Throughout pregnancy, the DHA content of plasma phospho- 
lipids of primigravida is significantly higher than that of 
multigravida, and a negative relationship was observed 
between DHA content and gravida number, which is reflected 
in neonatal DHA status and may have functional conse- 
quences for infant growth and development. Since increased 
supplies of selected PUFA during pregnancy may well have 
some benefits, the possible benefits as well as the potential 
risks of such strategies should be carefully evaluated. 
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4.1.5. Vitamins, minerals and trace elements. Relative 
to the increased energy needs (about lo%), the recom- 
mended relative increase of some other nutrients is 
markedly higher, for example, for folate the reference 
intake increases by 100% in pregnancy (Scientific Com- 
mittee for Food, 1993). Based on these considerations, the 
potential for an inadequate intake of one or more of these 
specific nutrients during pregnancy is greater than for total 
energy. 
During the latter part of pregnancy, the fetus 
has a high rate of Ca accretion in the order of 250-300 mg/ 
d. This appears to be partly accounted for by extensive 
adjustments in Ca metabolism during pregnancy, particu- 
larly the inhibitory effects of placental oestrogen on 
maternal bone resorption that result in an enhanced release 
of parathyroid hormone and, hence, increased maternal 
Ca absorption, decreased urinary excretion and enhanced Ca 
retention (Cole et al. 1987). Although low dietary Ca intakes 
of malnourished pregnant women have been associated with 
reduced bone mineral densities of the newborn infants 
(Ramam et al. 1978), in well-nourished mothers no 
enhancement of neonatal Ca accretion by increased 
maternal intakes has been demonstrated. However, at 
relatively low intakes, maternal body stores of Ca may be 
utilized and depleted to meet fetal needs (Duggin et al. 1974). 
In women with multiple pregnancies, in particular, low Ca 
intakes may increase the risk of osteomalacia at a later age. 
Although dental caries is relatively common during 
pregnancy, there is no evidence for a causal link of its rate 
of occurrence with dietary Ca intakes. 
Low Ca intakes during pregnancy have also been 
associated with the occurrence of EPH-gestosis (oedema, 
proteinuria and hypertension) as well as eclampsia (Burke 
et al. 1943). In a controlled study, supplementation of the 
diets of pregnant women with Ca was associated with a 
reduced systolic blood pressure at term and a lower inci- 
dence of pregnancy-induced hypertension (Villar et al. 
1987). In contrast, another study found no effect of a Ca 
supply on the incidence of pregnancy-induced hypertension, 
although mean blood pressure was lowered. 
Magnesium. Mg status is related to neuromuscular 
excitability, and it has been proposed that an additional 
Mg supply may contribute to prevention of eclampsia and 
other complications of pregnancy. However, controlled 
trials have not provided conclusive evidence for an 
improved course of pregnancy or delivery (Spatling & 
Spatling, 1988; Sibai et al. 1989). 
The total Fe needs for pregnancy have been 
estimated to be in the order of 300-850 mg (Bothwell et al. 
1979; Hallberg, 1988). Although the efficacy of Fe 
absorption is markedly enhanced in pregnancy, the 
incidence of Fe deficiency and Fe-deficient anaemia 
during pregnancy remains a sizeable problem that may 
increase maternal and fetal morbidity and mortality 
(Llewellyn-Jones, 1965), cardiovascular stress associated 
with increased complication rates before and at birth (Banks 
& Beutler, 1988) and an elevated risk of delivering low- 
birth-weight and premature infants (Scholl & Hediger, 
1994). At particular risk of poor Fe status in pregnancy are 
women with vegetarian or predominantly vegetarian diets, 
because of the relatively low absorption of non-haem Fe. 
Calcium. 
Iron. 
Thus, foods that promote net Fe absorption may be 
beneficial for some pregnant women. 
Maternal Zn deficiency is highly teratogenic in 
rodents, and in monkeys it induces abnormal fetal brain 
development (Worthington-Roberts 1985). Studies in 
human pregnancies found that maternal leucocyte Zn 
levels during pregnancy were correlated with later infantile 
birth weight (Wells et al. 1987) and inversely related to the 
rate of low-birth-weight infants (Neggers et al. 1991). 
Moreover, a better maternal Zn status was associated with 
lower rates of pregnancy-induced hypertension, protracted 
delivery and maternal complications at birth and the rate of 
premature rupture of membranes (Sikorski et al. 1990). In 
contrast, another controlled study evaluating Zn supple- 
mentation in the second and third trimesters of pregnancy in 
Europe did not find any effect. To what extent these 
differing results were influenced by variations in Zn status 
of the respective populations studied, and may be 
reproduced in other populations, remains to be clarified. 
In parts of Europe, the I status of many pregnant 
women is inadequate with a sizeable prevalence of 
increased thyroid size in mothers and newborn infants 
(World Health Organization, 1993). Poor I status is 
associated with an increased risk of miscarriage in early 
gestation and preterm delivery as well as compromised 
mental development of the infant (Xue-Yi et al. 1994). 
Fluoride. Since postnatal F- supply has a strong 
preventive effect on the incidence of dental caries, the 
question was raised whether an increased F- supply to 
pregnant women may contribute to protecting pre-eruptive 
teeth of the unborn child, but conclusive evidence to answer 
this question is not available. 
Folic acid is essential for the synthesis of 
pyrimidines, purines and hence of DNA and RNA, as well 
as amino acids and neurotransmitters; thus, an adequate 
folate status is of importance to allow undisturbed cell 
multiplication and growth during pregnancy. Following 
observations of a relation between folic acid status and the 
occurrence of neural tube defects in the offspring, several 
controlled clinical trials have demonstrated that folic acid 
supplied before conception and during the first weeks of 
pregnancy can markedly reduce the incidence of neural tube 
defects, such as spina bifida and anencephaly, by 40-70 % 
(Butterworth & Bendich, 1996). This important preventive 
effect is apparently associated with a folic acid-responsive 
derangement in homocysteine metabolism in a genetically 
determined subgroup of the population (Steegers- 
Theunissen et al. 1991). Poor folic acid status of pregnant 
women has also been associated with miscarriages, repeated 
abortions, pregnancy length and neonatal outcome as well 
as unexplained sterility (Pietrzik et al. 1992; Bung et al. 
1993, 1995). It has been recommended that all pregnant 
women should be supplemented with a daily dose of 0.4 mg 
folic acid from before conception to at least four completed 
weeks after conception (Scientific Committee for Food, 
1993). In view of the postulated key role of folic acid status 
in the aetiology of atherosclerosis by means of modulating 
homocysteine metabolism, the question of a potential 
programming effect of intrauterine folic acid supply on 
the later risk of cardiovascular diseases has been raised 
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5. Modulation of growth 
5.1. Introduction 
The term ‘growth’ expresses the increase in number and size 
of cells of a particular species and it refers to changes in 
body dimensions. Growth is a phenomenon usually asso- 
ciated with increase in length and weight whereas the term 
‘development’ is a physiological concept indicating the 
progressive differentiation of tissues and organs with acqui- 
sition of their specific functions. All mammals start life as a 
single cell; during the early part of the gestation the 
fertilized ovum divides many times and different kinds of 
cells develop during the process of differentiation and 
arrange themselves to form part of the various organs of 
the body. The general principles of growth apply to all 
species but the rate of cell division is genetically determined 
and depends on nutrient supply and utilization. Regardless 
of the exact time that differentiation occurs it always results 
in the transformation of the parental cell into a large number 
of morphologically different progeny cell types. The rapid- 
ity of physical growth is regulated during the life cycle and 
is modulated by genetics, a variety of growth factors that 
interact with target cells, as well as environment and diet 
(Hernindez & Argente, 1992; Philips, 1995). 
Human growth hormone (hGH) or somatotropin is essen- 
tial for normal postnatal growth. It is released from the 
anterior pituitary gland on stimulation by growth hormone- 
releasing hormone or somatocrinin, a factor produced by the 
hypothalamic region of the brain. Like other pituitary 
hormones, hGH acts on target tissues, primarily the liver, 
to cause synthesis and release of a second hormone 
mediator, insulin-like growth factor (1GF)-I, also called 
somatomedin C, into the systemic circulation. IGF-I is a 
growth-accelerating peptide that acts directly on cartilage to 
promote bone growth. Deficiency of hGH production causes 
metabolic alteration and growth failure (Philips, 1995). 
Different requirements for growth of different cell types 
have been established (Sato et aZ. 1982) but despite 
considerable progress in tissue culture systems we are still 
a long way from identifying all the stimulatory and inhibi- 
tory macromolecules that regulate the growth of all the 
human cell types in vivo. Most growth factors are polypep- 
tides or small proteins with molecular masses that vary from 
1 to 40 kDa and bind to specific cell surface receptors, with 
pleiotropic effects on cells including changes in gene 
expression (Watson et al. 1987). By binding to their 
receptors, growth factors modify the activity of the mem- 
brane-bound enzyme adenylate cyclase (EC 4.6.1. l), using 
the GTP-binding protein as an intermediate so that the level 
of CAMP in the cell is altered. This, in turn affects the 
activity of CAMP-dependent protein kinases which phos- 
phorylate specific target proteins, regulating their activity. 
Other possible second messengers to carry signals from 
growth receptors to the cell include Ca, inositol triphosphate 
and diacylglycerol (Lodish et al. 1995). 
In addition to genetic factors, neurohormonal and tissue- 
specific growth factors, growth is also affected by a number 
of metabolic and environmental factors which include the 
availability of nutrients. Recommended daily nutrient 
intakes have been established for all periods of life and 
both sexes to support an adequate growth of the human 
being (National Research Council, 1989). However, there is 
a lack of information about how semi-essential nutrients can 
affect growth in specific periods of life and in particular 
situations including disease states. 
The rapidity of physical growth in the normal infant 
during the first months of life is remarkable and unmatched 
during later times of life. Moreover, physiological and 
developmental changes during infancy are as notable as 
the speed of physical growth. Changes in the rates of 
physical growth and in the allocation of dietary intake of 
energy and protein for growth and maintenance occur as a 
continuum rather than in discrete stages, but the progression 
of changes during the early months of life is very rapid. 
Human milk provides all nutrients necessary to support 
adequate growth of the term infant during the first 4-6 
months of life. Furthermore, in addition to universally 
recognized nutrients, human milk contains a number of 
semi-essential nutrients, enzymes, hormones and growth 
factors which appear to have a role in supporting infantile 
growth (Koldovsky & Strbak, 1995). However, there is a 
lack of information about how those nutrients and factors 
interact with the growth process and how they affect specific 
tissue growth. 
5.2. Methods for the determination of growth 
Anthropometric measurements such as weight, length, head 
circumference, skinfold thickness, limb circumference, 
mid-am cross-sectional area, BMI etc. at various ages 
during infancy have been published in many developed 
countries and are useful in evaluating the size of an infant 
in relation to the size of his or her peers (Fomon & Nelson, 
1994). In the infant the Quetelet index is difficult to interpret 
since the body mass increases rapidly from birth to 4 months 
of age and the percentage of body weight contributed by 
body fat also increases rapidly during that period. Reference 
data for increments in size and other indices of nutritional 
status are more sensitive in children beyond infancy, 
particularly in alerting to the possibility of illness or nutri- 
tional inadequacy (Fomon, 1991). 
Data on body composition at various ages are one of the 
bases for the factorial approach in estimating the require- 
ments for various nutrients for growth. Chemical com- 
position of animals is determined by direct whole-body 
analysis. The most extensive data on the composition of 
the term infant are those published by Widdowson (1982), 
but data beyond infancy are scanty. The most useful indirect 
methods of estimating various aspects of body composition 
in the infant are determination of total body water from the 
concentration of a suitable tracer in body fluid, i.e. heavy 
water, extracellular water, and determination of natural 
abundance of 40K in the whole body (Forbes, 1987). 
Measurements of both bioelectric impedance and of total 
body electrical conductivity can estimate non-invasively the 
fat-free body mass of infants and children (Mayfield et aZ. 
1991; Houtkooper et aZ. 1992). Many new techniques are 
available for measurement of total body fat, although only a 
few can be used in general practice or in epidemiological 
research (Deurenberg, 1992). 
The urinary excretion rates of endogenous creatinine and 
3-methyl-histidine have been proposed as indices of muscle 
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mass, and the urinary excretion rates of endogenous hydrox- 
yproline and type I and type 111 procollagen propeptides as 
indices of growth rates (Trivedi et al. 1991). Measuring cell 
kinetics represents a new approach in evaluating cell and 
tissue growth. Cell kinetics can be used to measure the 
proliferation rate of cells, the phases of the cell cycle and the 
percentage of cells in cycle, to plot the position of dividing 
cells and determine the size of the proliferation compartment 
and to follow the movements of labelled cells. Cell kinetic 
studies received a boost when [3H]thymidine was introduced 
in the 1950s. Recently, several new techniques have been 
used in cell kinetics, i.e. incorporation of bromodesoxyuridine 
and labelling of cell antibodies (Kember, 1993). There is a 
need for new methods to evaluate the specific organ and 
tissue growth applicable in a wide range of conditions. 
5.3. Growth factors in human milk and their injuence on 
infant growth 
A large number of hormones and growth factors are present 
in human and bovine milks (Koldovsky & Thornburg, 1987; 
Strbak, 1991). Non-peptide hormones (thyroid hormones, 
cortisol, progesterone, pregnanediol, oestrogens and artifi- 
cial contraceptives) and peptide hormones and growth 
factors (erythropoietin, hGH, growth hormone releasing 
factor, gonadotropin-releasing hormone, epidermal growth 
factor (EGF), insulin, IGF-I, nerve growth factor, gastro- 
intestinal regulatory peptides and thyroid-parathyroid hor- 
mones) have been isolated and quantitated in human milk 
(Koldovsky & Strbak, 1995). The orogastric effects of 
hormones and growth factors on infant growth require 
further elucidation. However, there is some evidence that 
a number of hormones in human milk may contribute to the 
intestinal maturation of sucking infants. For example, oral 
administration of EGF to 10-d-old sucking rats resulted in 
changes in protein and DNA content of colonic mucosa 
(Koldovsky & Thornburg, 1987). 
5.4. Potential roles of non-protein nitrogen compounds as 
growth modulators 
Non-protein N (NPN) compounds are present in most foods 
mainly as nucleic acids, free amino acids, small peptides 
and other minor compounds. The concentration of nucleic 
acids in foods depends on the number of cells of the original 
biological tissue. Thus, meat, fish and vegetal seeds are rich 
in nucleic acids whereas fruits have a low content (Gil & 
Uauy, 1995b). NPN accounts for 18-30 % of the total N in 
human milk. Some of this N, namely urea, contributes to the 
pool available for synthesis of non-essential amino acids in 
infants. Other NPN components may have particular roles in 
tissue growth. Among the NPN known to have specialized 
roles in the ontogeny of the human newborn are the growth 
factors, namely EGF, amino sugar oligosaccharides, free 
amino acids like taurine, arginine and glutamine, amino 
alcohols of phospholipids i.e. choline, nucleotides and 
nucleic acids and polyamines. 
5.5. Human milk oligosaccharides and growth 
In addition to lactose, the carbohydrates of human milk 
include nucleotide sugars, glycolipids, glycoproteins, and 
oligosaccharides. Viverge et al. (1990) have isolated three 
oligosaccharide fractions representing 13- 18 g/l; the con- 
centration varied with the mother’s genetic ability to 
synthesize specific fucosyl linkages. Approximately eighty 
neutral and sialic acidic oligosaccharides have been isolated 
and identified (Newburg & Neubauer, 1995). 
Human milk oligosaccharides appear to be synthesized 
by some of the same glycosyltransferases that participate in 
the synthesis of glycoprotein and glycolipid cell surface 
components. Thus, it is reasonable to postulate that some of 
those compounds can act as analogues to host cell surface 
receptors for pathogens. Anderson et al. (1986) reported that 
specific oligosaccharides can inhibit binding of Streptococ- 
cus pneumoniae and Hemophilus injuenzae to their recep- 
tors and Cravioto et al. (199 1) described an oligosaccharide 
that inhibits adherence of enteropathogenic E. coli to their 
receptors. Other authors have reported that specific fucosyl- 
ated oligosaccharides inhibit binding of invasive strains of 
Campylobacter jejuni (Ruiz-Palacios et al. 1992) and the 
toxicity of E.coli in vivo (Newburg et al. 1990). 
Gangliosides are glycosphingolipids that contain sialic 
acid (N-acetylneuraminic acid) as part of their carbohydrate 
moiety. GM,, a milk ganglioside present in human milk, 
binds to E. coli and Vibrio cholerae toxins and may 
contribute to infant protection against infection by those 
enteropathogens (Laegrid et al. 1986). 
Since lactating mothers differ genetically in their ability 
to produce various oligosaccharides, this variability might 
influence the susceptibility of breast-fed infants to enteric 
disease. The influence of supplementing infant milk for- 
mulas with oligosaccharides on the susceptibility of infants 
to gastrointestinal diseases, namely acute diarrhoea, is one 
of the current fields of intense investigation. 
5.6. Free amino acids and tissue growth 
The free amino acid pool of human milk is small compared 
with the total amount of milk amino acids in protein. Free 
amino acids contribute only 10 % of the total NPN in human 
milk. Glutamine and taurine are the free amino acids found in 
higher concentrations in human milk. While clinical effects 
of low dietary intakes of taurine have not been demonstrated, 
there is a concern about the possibility of subclinical defi- 
ciency, particularly in the premature infant since its ability to 
synthestize taurine may be limited (Gaul1 et al. 1977). 
Free glutamine accounts for about 20% of the total 
glutamine pool in human milk. Glutamine is currently 
extensively investigated because of its importance in cell 
and tissue culture and because it serves as a preferred 
respiratory fuel for rapidly proliferating and growing cells, 
such as enterocytes and lymphocytes. Moreover, it is a 
regulator of acid-base balance through the production of 
urinary NH3, a carrier of N between tissues and an important 
precursor of nucleotides, amino sugars and proteins (Lacey 
& Wilmore, 1990). There is increasing evidence that gluta- 
mine may become a conditionally essential amino acid in 
critically ill patients, and glutamine appears to be important 
for the maintenance of small-intestinal structure and func- 
tionality (Newsholme & CarriC, 1994). 
Arginine and ornithine are also present in human milk as 
free amino acids, although the first is found in higher 
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concentrations in milk proteins. Arginine has multiple 
biological properties, including the ability to stimulate 
anabolic hormone secretion: intravenous and enteral admin- 
istration of arginine increases both insulin and hGH secre- 
tion (Cynober, 1994). Several studies show that arginine 
given to patients, as well as in various experimental stress 
models, acts by improving N balance, accelerating wound 
healing, and restoring depressed immunity. Dietary supple- 
ments of arginine have been shown to inhibit tumour growth 
in animals, probably by activating the immune system. 
However, in cancer patients arginine stimulates tumour 
protein synthesis, suggesting that arginine might have 
separate stimulatory effects on the tumour and on the 
immune system, the outcome depending on which effect 
predominates (Garlick & McNurlan, 1994). Arginine has 
also been shown to enhance the growth-hormone-releasing- 
hormone-induced hGH rise in patients with anorexia ner- 
vosa (Ghigo et al. 1994). Moreover, oral administration of 
arginine enhances the hGH response to growth hormone 
releasing hormone in short children (Loche et al. 1993). 
Ornithine shares with arginine the ability to stimulate 
hGH secretion. In addition, ornithine as its a-ketoglutarate 
salt generates various molecules, i.e. glutamine. Ornithine 
ketoglutarate has been shown to improve N balance in 
various acute and chronic malnutrition states. It increases 
muscle protein anabolism in moderate catabolic states and 
reduces protein catabolism in hypercatabolic states 
(Cynober, 1994). 
Arginine and ornithine are precursors of NO and 
polyamines respectively. These metabolites participate inti- 
mately in permeability and adaptive responses of the gut. 
Recent animal studies showed improved morphology after 
ornithine ketoglutarate administration, acting perhaps 
through increased polyamine synthesis (Cynober, 1994). It 
is controversial whether exogenous arginine can be a 
relevant precursor of polyamines. 
5.7. Polyamines and tissue growth 
Polyamines are detectable in relatively high quantities in 
human and rat milk. Artificial infant formulas do not contain 
appreciable amounts of polyamines, specifically putrescine 
and spermidine, and spermine is undetectable. Thus, 
formula-fed infants are not exposed to polyamines nor to 
any potential effects that these compounds may have on the 
developing intestine. It is noteworthy that food contains 
polyamines and that polyamines are produced by the gastro- 
intestinal microflora. Thus, the direct uptake by enterocytes 
of preformed polyamines could contribute to the polyamine 
cellular pool. Indeed, putrescine and spermidine uptake 
has been shown in isolated rat enterocytes (Cynober, 
1 994). 
5.8. Dietary nucleotides and tissue growth 
Human milk is the exclusive source of dietary nucleotides 
for infants during the first months of life, and its nucleotide 
profile (Gil & SBnchez-Medina, 1982; Gil & Uauy, 1995a) 
differs markedly from that of cow’s milk and most infant 
formulas (Gil & SBnchez-Medina, 1981; Gil & Uauy, 1989, 
1995~). Preformed nucleotides may be of importance for the 
growth of tissues with a rapid turnover (Van Buren et al. 
1985; Nuiiez et al. 1990; Uauy et al. 1990; Gil & Uauy, 
19953), particularly bone marrow, leucocytes and the intest- 
inal mucosa which preferentially use the nucleotide salvage 
pathway to fulfil their purine and pyrimidine nucleotide 
requirements (Mackinnon & Deller, 1973; Savaiano & 
Clifford, 1981; LeLeiko et al. 1983; Cohen et al. 1984). 
Dietary nucleotides may modulate lipoprotein and fatty 
acid metabolism in human early life (Gil et al. 1986b, 1988; 
De-Lucchi et al. 1987; Pita et al. 1988; Morillas et al. 1994; 
S6nchez-Pozo et al. 1994), and they may enhance the 
growth of bifidobacteria and limit that of enterobacteria in 
the gut of newborn infants (Gil et al. 1986a; Gil & Uauy, 
1995). Dietary nucleotides may affect small-intestinal 
growth in experimental animals (Gil & Uauy, 1995) and 
may have a role in the maintenance of the immune response 
both in animals (Van Buren et al. 1983, 1985; Pizzini et al. 
1990; Kulkarni et al. 1992) and in human subjects (Carver et 
al. 1991; Gil & Uauy, 1995). 
5.8.1. Nucleotides and small intestine growth. A 
number of factors are involved in the regulation of the 
renewal of the absorptive epithelium and in the repair of the 
epithelium under pathological conditions (Shiner et al. 
1990). N-containing nutrients appear to be important for gut 
growth. At weaning, protein modulates the ontogenic 
changes in tissue DNA synthesis and plays a role in 
completing the growth of the rat’s gastrointestinal tract 
(Buts & Nyakabasa, 1985). Dietary nucleotides have been 
shown to influence gut development and repair after injury. 
Uauy et al. (1990) reported that intestinal disaccharidase 
activities are increased in rats during development by 
dietary nucleotides, and DNA, lactase (EC 3.2.1.23), 
sucrase (EC 3.2.1.48) and maltase (EC 3.2.1.20) activities 
increase with a nucleotide-supplemented diet in animals 
after chronic diarrhoea (Nuiiez et al. 1990; Bueno et al. 
1994). Dietary nucleotides promote the enterocyte growth in 
tissue culture (He et al. 1993; Sanderson & He, 1994) and 
improve the intestinal repair in an animal model of radiation 
injury (Uauy et al. 1994). Recent studies on the potential 
roles of exogenous nucleotides on proliferation, differentia- 
tion and apoptosis of human small-intestinal epithelium 
have shown that AMP may have an important role in 
controlling the dynamic balance of cellular turnover in the 
developing human small intestine (Tanaka et al. 1996). 
Moreover, dietary nucleotides influence the gene transcrip- 
tion in the intestine (LeLeiko et al. 1995). Animals 
receiving a purine and/or pyrimidine-free diet have a 
decreased protein synthesis and RNA throughout the 
intestine and specific mRNA for the enzymes hypoxanthine 
phosphoribosyltransferase (HGPRT) and adenosine phos- 
phoribosyltransferase (APRT) (LeLeiko et al. 1987). A 
35-base pair region identified in the HGPRT promoter is 
necessary to confer sensitivity to exogenous purines as a site 
for binding to trans-acting regulatory proteins (Walsh et al. 
1990, 1992). 
5.8.2. Nucleotides and liver growth. Extracellular 
nucleotides and nucleosides have been reported to modulate 
hepatocyte growth (Ohyanagi, 1989; Gil & Uauy, 19953) 
and regeneration and to play an important role in the 
synthesis of glycogen (Buxton et al. 1986). Ogoshi et al. 
(1985, 1988) reported that parenterally administered 
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nucleotides improved the hepatic function and promoted 
earlier restoration of the N balance after liver injury or partial 
hepatectomy. Moreover, it has been observed that adenosine 
administration partially prevents cirrhosis induced by CC14 in 
rats due to a stimulation of total hepatic collagenase activity 
and is able to counteract the drastic decrease in adenine 
nucleotides (Hemhdez-Muiioz et al. 1990). 
Deprivation of dietary nucleotides results in a transient 
decrease in acid-soluble nucleotides and RNA content in rat 
liver as well as in a decreased protein synthesis rate (L6pez- 
Navarro et al. 1995). Dietary nucleotides have improved 
liver structural recovery and binuclearity in experimental 
cirrhosis induced by thioacetamide (Torres et al. 1996). In 
that model dietary nucleotides led to a lower number of 
stellate cells and to a lower collagen deposition. 
5.9. Long-chain polyunsaturated fatty acids and cell growth 
Despite recent advances in neonatal care, low-birth-weight 
infants do not achieve first year growth equivalent to that of 
infants born at term. It has not been clarified how the 
administration of long-chain fatty acids to infants may 
affect growth and specific tissue growth and differentiation. 
Direct evidence that normalized growth might relate to 
arachidonic acid status came from the observation that 
formula supplemented with marine oil but no arachidonic 
acid decreased the concentrations of plasma phosphatidyl- 
choline arachidonic acid (Carlson et al. 1991) and reduced 
weights compared with standard formula without marine oil 
(Carlson et al. 1992). Phosphatidylcholine arachidonic acid 
declined in preterm infants fed on non-supplemented for- 
mulas, and weight fell progressively beginning at 2 months 
of age. The nadir of plasma phosphatidylcholine arachido- 
nic acid and growth was further reduced by formula contain- 
ing marine oil compared with the non-supplemented 
formulas (Carlson et al. 1993). 
Koletzko & Braun (1991) have investigated whether birth 
weight correlates with the postnatal EFA status in premature 
infants. A significant and positive correlation between body 
weight and plasma triacylglycerol content of arachidonic 
acid and total n-6 long-chain-PUFA was found as well as a 
negative correlation with a-linolenic acid. 
There is only limited information about how intakes of 
n-6 and n-3 long-chain-PUFA may affect specific tissue 
growth. Animal studies using diets supplemented with both 
types of fatty acids have shown that in addition to plasma 
and erythrocyte cell membranes, small intestine, liver, 
kidney, lung and heart are affected in their fatty acid 
composition. Depending on the composition of the diet, 
susceptibility to oxidation may be affected, which might 
influence tissue growth and function (Suarez et al. 1996a,b). 
5.10. Early growth and later obesity 
In animal studies, early overfeeding may have lasting 
effects on nutrient utilization and body composition 
(Davis et al. 1973; Lewis et al. 1986). In male infants of 
pregnant women who suffered from starvation, obesity in 
young adulthood was more prevalent if the mothers were 
exposed to the famine during the first half of gestation, 
while the incidence of later obesity was reduced if starvation 
occurred during late gestation and the early postnatal period 
(Ravelli et al. 1976). Also, food composition, and particu- 
larly protein intake, in early childhood has been suggested 
as a predictor of later risk of obesity. In view of the high 
prevalence of obesity in Europe and its major importance 
for public health and health-care costs, the potential 
modulation of later obesity by early food choice needs to 
be further explored. 
6. Maturation of the gastrointestinal tract 
6.1. Introduction 
Digestion and hydrolysis of macro- and micronutrients by 
the gastrointestinal tract are essential prerequisites for long- 
term survival of mammals including man. Proteins, fats and 
carbohydrates are digested and hydrolysed by a variety of 
potent excretory glands and by the brush-border enzymes of 
the small intestine as well as by bacterial breakdown within 
the large intestine. As for carbohydrates, a cascade of 
hydrolytic events finally leads to the presence of mono- 
saccharides within the lumen of the gastrointestinal tract 
which are transported across the microvillus membrane by 
highly specialized transporters. Carbohydrates with high 
molecular mass in the form of amylose and amylopectin 
are hydrolysed by a-amylase (EC 3.2.1.1) of the saliva and 
the pancreas. a-Amylase can hydrolyse 1 -4-a-glycosidic 
bonds which are present in both amylose and amylopectins. 
The branches of 1-6-a-glycosidic side chains in amylo- 
pectins remain after the action of a-amylase as a-limit- 
dextrins, and are further hydrolysed by sucrase-isomaltase 
(SI) (Gray, 1967). Hydrolysis of starches is dependent on 
the age of the infant. In the first 6 months of life, activity of 
a-amylase is low and reaches full activity at the end of the 
first year of life (Lentze, 1986). Defects in sugar digestion 
occur because of disturbances within the combined action of 
pancreatic a-amylase and that of intestinal brush-border 
enzymes. Decreased digestion and hydrolysis of carbohyd- 
rates will induce either osmotic diarrhoea and/or bacterial 
overgrowth within the small intestine as well as bacterial 
breakdown of carbohydrates within the colon. 
Malnutrition is very often combined with chronic 
diarrhoea and damage of the gastrointestinal mucosa as a 
consequence of lack of protein and energy. Key factors in 
this devastating cascade are the brush-border membrane of 
the small intestine and its hydrolysing and absorptive capa- 
city. Important observations with regard to the hydrolytic 
capacity of intestinal disaccharidases, which are responsible 
for sugar hydrolysis, have come through the study of their 
intracellular pathways and processing of enzyme molecules 
in normal and altered human as well as animal mucosa using 
various techniques of molecular biology. The knowledge of 
these investigations has considerably increased our under- 
standing as to how carbohydrates are hydrolysed and 
absorbed from the intestinal epithelial cell. 
6.2. Development of sugar hydrolases and transporters 
The morphological development of the small intestine starts 
in the 9th week of gestation from the proximal to the distal 
part of the gut (Hauri, 1986). Small villi develop over a 
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stratified epithelium of several layers. The first crypts are 
seen at the age of 10-11 weeks gestation within the 
duodenum and jejunum, and at 11-12 weeks in the ileum 
and colon. The changes into a columnar epithelium occur 
together with the appearance of secondary lumina visible by 
electronmicroscopy and parallel invagination of mesenchy- 
ma1 cells and extrusion of surface cells (Naim et al. 1988). 
The development of a brush-border membrane is seen 
together with crypt development in the 10-12th week of 
gestation. At the same time brush-border membrane hydro- 
lases start to appear. Lactase-phlorizin-hydrolase (LPH), SI 
and maltase-glucoamylase are first detectable at the 10th 
week of gestation (Dahlqvist & Lindberg, 1965). Their 
enzymic activities increase during gestation. As SI and 
maltase-glucoamylase reach their full activities by the 
25th week of gestation (Jirsova et al. 1965-6), the activity 
of LPH remains low until the 28th week of gestation and 
increases slowly between the 32nd and 34th weeks of 
gestation (Dahlqvist & Lindberg, 1966). For the nutrition 
of very immature premature babies with very low birth 
weight between the 26th and 28th weeks of gestation this 
could play a role in the digestion and hydrolysis of lactose 
given in breast milk or infant formula. After introduction of 
lactose-containing milk the activity of LPH matures quickly 
to normal enzymic activities. The glucose transporters in the 
small intestine develop during gestation at about the same 
time as the sugar hydrolases. Sodium-dependent glucose 
transporter 1 (SGLT l), glucose transporter (GLUT) 5 and 
GLUT 2 appear at the 1 lth week of gestation as seen by the 
expression of specific mRNA in human fetal intestine 
(Davidson et al. 1992). 
6.3. Biosynthesis of intestinal brush-border membrane 
hydrolases 
Mature intestinal epithelial cells are highly polarized and 
are composed of two main membranous regions: the apical 
cell membrane, with its unique feature of a brush border, 
and the basolateral membrane. The microvillar membrane is 
characterized by a network of microvilli which contain the 
important glycoproteins responsible for the hydrolysis and 
absorption of micronutrients and minerals. For the degrada- 
tion of various sugar and peptide molecules of different 
composition and chain length, the intestinal disaccharidases 
SI, maltase-glucoamylase, LPH, trehalase and a variety of 
peptide hydrolases are present within the microvillar region 
of the columnar epithelia in order to digest carbohydrate 
molecules and oligopeptides from nutritional intakes. The 
disaccharidases are the best studied brush-border hydro- 
lases. Their enzymic activities and their distribution 
throughout the gastrointestinal tract as well as their age 
dependency have been investigated by many groups of 
researchers. The biogenesis of the disaccharidases produced 
and processed by the mature enterocyte has been elucidated 
in mammals as well as in man, demonstrating common 
pathways within the translational and post-translational 
routes. 
SI and LPH are the best studied brush-border membrane 
hydrolases in all species including man. The data accumu- 
lated from these studies have led to a general understanding 
as to how these hydrolases are synthesized and processed 
within the small-intestinal enterocyte. After transcription a 
single-chain precursor (pro-SIh) rich in mannose (high 
mannose precursor) is produced in the rough endoplasmic 
reticulum. This contains carbohydrate residues which are 
N-glycosylated and has an apparent molecular mass of 
210kDa in human subjects (Hauri et al. 1980; Ghersa et 
al. 1986). From the rough endoplasmic reticulum the pro- 
SIh is transported to the Golgi apparatus where trimming of 
the mannose residues and addition of complex carbohy- 
drates occur to yield pro-SIC (molecular mass 245 kDa) 
(Hauri et al. 1982). The complete primary structure of the 
pro-SI from rabbit is composed of 1827 amino acid residues 
containing the two active catalytic subunits isomaltase 
(140kDa) and sucrase (120kDa) which are associated by 
oncovalent, ionic interactions (Sjostrom et al. 1980). After 
complex glycosylation in the Golgi the pro-SIC is trans- 
located and inserted into the microvillus membrane by 
vesicular transport directly into the apical microvillus 
membrane. The exact route for the transportation of glyco- 
proteins from the Golgi to the microvillar membrane 
remains to be established. The time course of transport of 
the pro-SIC from the Golgi into the brush-border membrane 
in a human colon carcinoma cell line (CaCo-2 cells) is 
rather slow (Herskovics et al. 1981). Similar transport 
kinetics were also obtained when the biosynthesis of SI 
was investigated in the organ culture of human intestinal 
explants (Naim et al. 1988). Insertion of pro-SIC into the 
microvillus membranes is obtained by anchoring a single 
hydrophobic segment of the molecule which is located at the 
N-terminus of isomaltase (Hauri et al. 1986). After insertion 
into the microvillar membrane pro-SIC is cleaved into 
sucrase and isomaltase by pancreatic proteases (Naim et 
al. 1988). The mature catalytic enzymes sucrase and 
isomaltase cleave various substrates including sucrose, iso- 
maltose, maltose, maltotriose and amylose as well as a-limit 
dextrins which are derived from the hydrolysis of amylo- 
pectins. SI, together with maltase-glucoamylase, plays a 
major role in starch digestion during the first month of life as 
a-amylase in human infants is not developed during the first 
6 months of life (Danielsen et al. 1981). Striking structural 
and functional similarities suggest that intestinal SI, human 
lysosomal a-glucosidase and Schwanniomyces occidentalis 
glucoamylase are derived from a common ancestral gene 
(Naim et al. 1991). 
LPH, as the only 0-glycosidase of the brush-border 
membrane, has been reported in earlier work to be synthe- 
sized also as a single-chain precursor with a molecular mass 
of 150kDa (Sjostrom et al. 1983). However, conflicting 
results were obtained on the structure and identification of 
the precursor molecules. In the pig a precursor protein of 
200kDa was observed (Danielsen et al. 1984). The same 
group reported in a more recent publication that the pre- 
cursor molecule of LPH in the pig small intestine is a 
membrane-bound polypeptide of 225 kDa which is intra- 
cellularly cleaved after complex glycosylation (Mantei er al. 
1988). Similar data were obtained in CaCo-2 cells 
(Herskovics et al. 1981). In human intestinal epithelial 
cells a high-mannose precursor of 215 kDa was demon- 
strated in intestinal explants maintained in organ culture 
(Hauri, 1986). Here the intracellular cleavage of the high- 
mannose precursor occurs during the translocation of the 
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molecule across the Golgi before complex glycosylation 
takes place. The mature form of LPH is then inserted into 
the membrane with a molecular mass of 160kDa. The 
primary structure of the human lactase molecule is known 
and comprises 1927 amino acids in man and 1926 amino 
acids in the rabbit (Messer & Kerry 1967). The place at 
which the mature form of lactase is cleaved from its 
precursor is position 866 of the whole molecule. In contrast 
to most other brush-border membrane hydrolases the mature 
lactase is anchored within the lipid bilayer from its carboxyl 
end of the protein chain (Messer & Kerry, 1967). 
Maltase-glucoamylase hydrolyses 1-4-a-glycosidic- 
linked glucose polymers including maltose and maltotriose 
(Naim et al. 1989). The enzyme is developed early in 
gestation and contributes to the digestion of starch after 
birth. The biosynthesis of maltase-glucoamylase is similar 
to that of SI as a precursor molecule of 225 and 245kDa. 
The former represents the high mannose and the latter the 
complex glycosylated precursor of maltase-glucoamylase 
in the pig small intestine (Danielsen et al. 1984). The 
biosynthesis and processing of maltase-glucoamylase in 
human intestinal biopsy specimens does not involve intra- 
cellular or extracellular proteolytic modifications, in 
contrast to SI and LPH (Pfeffer & Rothman, 1987). 
6.4. Intestinal absorption of glucose and fructose 
Our current understanding of glucose (galactose) and fruc- 
tose is that the monosaccharides are transported by different 
methods into the intestinal absorptive epithelial cells. 
Whereas SGLT 1 is responsible for the active transport of 
glucose or galactose with equimolar amounts of Na against 
a concentration gradient into the cytoplasm of the enter- 
ocyte (Crane 1973, fructose undergoes facilitated transport 
by the GLUT 5 transporter which is also located on the 
brush-border membrane (Davidson et al. 1992). Once taken 
up into the enterocyte, Na' is exchanged with K+ by the 
Na', K+-ATPase (EC 3.6.1.3) which is located in the 
basolateral membrane and glucose is pumped into the 
intracellular space by another glucose transporter protein, 
GLUT 2. GLUT 2 has also been shown to be localized 
within the basolateral membrane. The function of SGLT 1 is 
essential for survival of a given species such as man. When 
absent or deficient, as in congenital glucose-galactose 
malabsorption, the malfunction of SGLT 1 is a lethal factor. 
The absorption of these simple monosaccharides when 
present in the intestinal lumen is dependent on a variety of 
factors contributing to the rate of absorption. It is dependent 
on age, composition of food and species. In mice a relation- 
ship between the type of diet and sugar uptake was demon- 
strated. When fed on a high-carbohydrate, low-protein 
chow, the uptake of glucose remained high, and dropped 
considerably when the mice were put on a low-carbohy- 
drate, high-protein diet (Karasov et al. 1983). Moreover, it 
was shown that a strong correlation exists between glucose 
uptake and the type of natural diet within various vertebrate 
species. The more herbivore the species is, the more glucose 
is absorbed; the more carnivore the species is, the less 
glucose is taken up (Riby et al. 1993). Fructose absorption 
depends strongly on the presence of other carbohydrates 
within the intestinal lumen. Fructose given together with 
glucose, galactose, sucrose or starch is better absorbed than 
fructose alone (Fujisawa et al. 1991) whereas the presence 
of sorbitol or dextrin leads to fructose absorption as with 
fructose alone. Species differences have a considerable 
influence on fructose absorption which depends entirely 
on the composition of the natural diet. Whereas the carni- 
vores (cats) have a low fructose absorption after weaning, 
the rat and the rabbit increase their fructose absorption 
considerably after weaning (Buddington & Diamond, 
1989). 
The complete mechanism for fructose absorption from 
the human intestine remains to be elucidated. A model of 
fructose absorption can be deduced from animal studies as 
well as from human studies. The rate of fructose absorption 
is influenced by glucose, but also by the amino acid 
glycine. Two mechanisms have been proposed to explain 
this effect. Fujisawa et al. (1991) speculate that a mechan- 
ism in the brush-border membrane exists which they call the 
disaccharidase-related transport system. This speculation is 
based on their findings that the specific inhibitor of SI, 
acarbazone, decreases fructose absorption when given with 
sucrose, whereas absorption increases without the inhibitor. 
Another explanation could well account for this effect: 
glucose absorption as well as glycine absorption increases 
the water flow from the lumen into the intercellular space by 
osmosis. Therefore, a solvent drag occurs leading to an 
enhanced uptake of fructose. The same mechanism applies 
when starches or sucrose are present at the same time as 
fructose because of the rapid hydrolysis of these carbohy- 
drates to glucose and/or fructose by the action of maltase- 
glucoamylase and SI. In order to elucidate this effect 
fructose absorption should be studied in individuals with 
SI deficiency which would be the equivalent model to the rat 
intestinal fructose uptake studies with acarbazone. Except 
for LPH, the activities of other sugar hydrolases as well as 
SGLT 1 can be influenced by substrates (Buddington et al. 
1991; Quan & Gray, 1993). The close presence of sugar 
hydrolases and sugar transporters within the microvillar 
membrane of the small-intestinal enterocyte as well as the 
transporters for amino acids is the guarantee of a steady 
uptake of sugars derived from various sources. 
6.5. Oligosaccharides and mucins 
Besides the most abundant sugar lactose, human milk 
contains more than 130 different oligosaccharides and is 
unique among all mammalian species for its content of 
higher oligosaccharides, i.e. larger than lactose. For a long 
time the oligosaccharide fraction in human milk has been 
overlooked although it is the third largest solute (up to 18.5 
g/l) and present in higher amounts than protein (Egge et al. 
1983). As oligosaccharides escape the hydrolysis in the 
small intestine, two possible functions are discussed. One 
function would be the intact absorption of these components 
serving as substrates for organ maturation such as the 
brain, where rapid synthesis of sialoglycoproteins and 
gangliosides occurs (Sabhanval et al. 1991). Their role in 
the large bowel as 'dietary fibre' and their fermentation 
would be of significant value in nutrition. The oligosac- 
charides in human milk are based on five monosaccharide 
residues: sialic acid, N-acetylglucosamine, fucose, glucose 
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and galactose. All oligosaccharides possess a lactose moiety 
at their reducing end, with sialic acid (when present) and 
fucose at the non-reducing end. The chain length varies 
between three and eleven units. The oligosaccharide com- 
position of human milk shows temporal and individual 
variations (Miller et al. 1994). At the same stage of lactation 
the variation in oligosaccharide content was shown to be 
fourfold. 
Recent findings on the chemical structure of oligo- 
saccharides in milk have demonstrated structural homolo- 
gies to carbohydrates carried by glycoproteins and 
glycolipids on cell surfaces. Such oligosaccharides are 
very antigenic and were targets of monoclonal antibodies 
in the search for specific binding to human cancer cells. 
Similar novel oligosaccharides which can inhibit antigen- 
antibody reactions have been detected in human milk 
(Fievre et al. 1991; Kitagawa et al. 1991). They are useful 
hapten inhibitors to study the binding specificities of anti- 
carbohydrate antibodies produced as mucins on cancer cells. 
This observation has great clinical implications with respect 
to breast cancer. High-molecular-mass glycoproteins 
(MUCI) in milk and lactating tissue have been found to 
contain up to 80% of carbohydrates. The low level of 
expression of MUCl in healthy, undifferentiated (non- 
lactating) breast tissue, and its presence in many, particu- 
larly metastasizing, breast tumours has established a very 
useful marker in breast cancer screening. The exact nature 
of MUCl, its biological role and expression, has been 
studied in milk and mammary tissue (Patton et al. 1995). 
MUCl as expressed in tumours activates B- and T-lympho- 
cytes. These epitopes represent underglycosylated forms of 
MUCl characteristic of breast and pancreatic cancer. It is 
also responsible for keeping ducts and lumens, such as the 
mammary ducts, open. Here it binds also to L-selectin 
which is expressed on the surface of leucocytes. By this 
action leucocytes are bound to the lumen and excreted 
into the milk (Welply et al. 1994). It also escapes digestion 
and is excreted in the stools of breast-fed infants. In the 
colon it binds to micro-organisms, particularly to the 
fimbrins of E. coli, contributing to the host defence of 
the breast-fed infant (Cravioto et al. 1991; Schroten et al. 
1993). 
6.6. Probiotic substances in milk or milk substitutes 
There are indications that certain ingested micro-organisms 
added to milk or milk products may exert some physio- 
logical effects and promote health in human infants. Such an 
example is the use of Lactobacillus GG added to the milk 
formula for premature infants. After administration of these 
bacteria to premature infants it was noted that the bowel was 
colonized by Lactobacillus GG, and no clinical side-effects 
were seen. However, no clinical benefit was noted either 
(Millar et al. 1993). As far as potential effects on fermenta- 
tion are concerned, Lactobacillus GG given to premature 
infants had no effect on production of short-chain fatty acids 
in stools. The observed small increase in ethanol excretion is 
unlikely to have any clinical significance (Stansbridge et al. 
1993). Whether or not pre- and probiotics modulate gut 
maturation and have relevant health benefits in infancy 
remains to be elucidated. 
6.7. Dietary regulation of xenobiotic metabolism 
The nutritional status or specific nutrients may influence the 
metabolic capacity of the liver, but also of other organs 
(intestinal mucosa). The exact mechanism of drug-nutrient 
interaction remains unknown. Moreover, the health effects 
of such interactions have to be explored. 
Diet could modulate the metabolism either through an 
action on substrate availability or by modifying key 
enzymes of metabolism. The influence of starvation on 
conjugation and glucuronidation illustrates this point 
(Mandl et al. 1995). 
One important discovery of recent years is that some 
components of food (antioxidants like butylated hydroxy- 
toluene) are able to modulate the activity of key enzymes of 
phase 1 or 2 metabolism, by modifying gene expression 
(Kashfi et al. 1994). This is a promising area that requires 
further work. In fact the modulation of gene expression by 
nutrients is well described in the context of the influence of 
food on carbohydrate or lipid metabolism but the effect of 
macro- or micronutrients on xenobiotic-metabolizing 
enzymes (XME) remains unelucidated. 
Diet may also influence XME by inducing specific 
pathology e.g. steatosis. The part played by nutrients and 
morphological alteration in the modification of XME has to 
be established (Leclercq et al. 1996). 
Specific components of food (n-3 PUFA), even at very 
low concentrations (piperine from black pepper, naringen- 
ine from grapefruit) may modify the activity of specific 
isoforms of XME (e.g. glucuronosyltransferases) (Speck et 
al. 1991). This could lead to interesting developments in 
several fields. (1) Fundamental research: it will help in 
studying this metabolic reaction in detail by using those 
nutrients as activators or specific inhibitors. (2) Those 
nutrients which can be used at low dose could, thus, be 
considered as ‘toxico-modulators’ . (3) Such compounds 
have been proposed as therapeutic adjuvants, allowing 
reduction of the dose of expensive drugs, or drugs with a 
low safety-therapeutic index. The discovery of new nutri- 
ents with new targets could constitute a very promising area. 
Finally, the validation of experimental models (and parti- 
cularly in vitro models) allowing the study of drug-nutrient 
interactions would give a new input in this area. 
7. Development of the immune system 
7.1. Introduction 
Positive effects of particular foods or food ingredients on 
the human immune system (e.g. inhibition of CHD and 
cancer development etc.) could conceivably be related to 
early nutritional events or may only be seen after decades of 
intake or lifestyle changes. An important unresolved issue is 
whether there are critical time periods during which a 
provision may be especially beneficial to the immune 
system. In view of these difficulties, in vitro surrogate 
markers for study end-points are frequently used. A surro- 
gate end-point can be defined as a laboratory measurement 
or a physical sign used as a substitute for a meaningful end- 
point that measures directly how a patient feels, functions or 
survives. Changes to a surrogate end-point induced by a 
dietary intervention are expected to reflect changes in a 
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biologically meaningful end-point. However, surrogate end- 
points do not always reflect the true clinical outcome and 
can be misleading or even meaningless (Fleming & DeMets, 
1996). Other important limitations of studies reporting 
effects on the development of immunity are: 
short duration; 
lack of standardized tests; 
lack of correlation of in vitro and/or in vivo findings with 
immune protection or immune suppression; 
lack of demonstration of health-enhancing effects in a 
developing normal, presumably non-deficient population 
of infants, but with changing nutritional requirements. 
7.1.1. Which constituents of the immune system to 
investigate? The immune system is a highly complex 
regulatory cellular and humoral system of protection and 
stimulation directed to avoid danger to the host. On this 
basis a possible role of diet in cancer prevention could be 
taken as summary evidence for beneficial effects of the diet 
on the immune system. This extrapolation, however, seems 
highly conjectural since it would argue that a number of 
cancers are due to deficient immune surveillance mechan- 
isms. This may or may not be the case and a number of other 
protective mechanisms could be equally plausible. 
The present report focuses separately on published evi- 
dence mostly in infants and children and, where appropriate, 
in normal individuals and animals. Parenteral micronutrient 
supplementation in disease states or after surgery, low level 
toxicity and multiple chemical sensitivities will not be 
addressed. 
7.1.2. Special considerations for the immune system of the 
developing child. There is a dearth of reliable information of 
the effects of vitamins, saturated and unsaturated fatty acids, 
trace minerals and other normal food constituents on the 
infant’s developing immune system. The majority of reports 
examine the effects of corrections of severe or moderate 
deficiencies on the immune responses in infants and 
children (or animals). Very little is known of the effects 
of supplementations, either in line with recommendations or 
above, in a non-deficient population. As indicated earlier, 
most measurements have been related to surrogate end- 
points and the relationships between administration of test 
substances and their effects on the immune system are not 
strongly causal. 
7.2. Antioxidants and vitamins 
7.2.1. In general. Antioxidant vitamins generally enhance 
different aspects of cellular and non-cellular immunity. The 
antioxidant function of these micronutrients could, at least 
in part, enhance immunity by maintaining the functional and 
structural integrity of important immune cells. Multiple 
effects attributed to antioxidants include risk reduction of a 
variety of chronic diseases (Messina & Messina, 1996), 
anti-(retro)-viral activity (Formica & Regelson, 1995), 
immune enhancement in animals (Forni et al. 1986; 
Gebhard et al. 1990, ), in man (Chavance et al. 1989; Penn 
et al. 1991; Rall & Meydani, 1993), and evidence that certain 
vitamins alone or in combination and other micronutrients 
given in levels above the current recommendations have 
critical, beneficial effects on human immune responses 
(Bendich, 1995). 
The effects of vitamin A supplemen- 
tation on measles in deficient and non-deficient children 
have been the subject of several recent reports (Coutsoudis 
et al. 1992, 1995; Rosales & Kjolhede, 1994; Semba et al. 
1995; Stabell et al. 1995; Keusch, 1996). In general, in the 
last decade epidemiological, immunological, and molecular 
studies have yielded substantial evidence for a central role. 
The recent discovery of retinoic acid and retinoid X 
receptors has provided a molecular basis for the action of 
vitamin A and its metabolites at the level of gene activation. 
&Carotene supplementation enhances the expression of 
functionally associated molecules on human monocytes 
(Hughes et al. 1996) and also enhances immune responses 
to poor immunogens, which may be relevant to infants 
receiving vaccines which are characterized by low ser- 
oconversion rates (Semba, 1996), however under certain 
conditions seroconversion rates may be negatively affected 
too (Semba et al. 1995). No difference was found (using 
whole-blood culture techniques) in the in vitro proliferative 
responsiveness of T-cells to concanavalin-A and tetanus 
toxoid of children with normal or low-normal concentra- 
tions of vitamin A or Zn (Kramer, 1996). 
Vitamin C has gained great scientific 
and media attention through the promotions of its effects on 
the common cold. Early reports of systemic conditioning of 
infants following an increased intake of vitamin C during 
development seem to have been unfounded (Gerster & 
Moser, 1988). Studies which failed to identify a positive 
effect on the symptoms of the common cold have recently 
been critically reviewed and it now seems likely that there is 
a reduction in clinical symptoms associated with intake of 
2-3 g ascorbic acidd at the onset of the cold (Hemila, 
1996). 
Few studies have addressed 
the effects of supplementation with individual B vitamins 
and/or the coenzyme CQlO. When studied, positive 
enhancing effects on cell-mediated immunity, CD4 : CD8 
ratios, delayed type hypersensitivity and antibody produc- 
tion have been reported (Gebhard et al. 1990; Miller & 
Kerkvliet, 1990; Folkers et al. 1993). Tumour inhibition by 
high dietary pyridoxine may be mediated by immunological 
mechanisms that are lacking in the genetically immuno- 
deficient (athymic) mice in which these studies have been 
carried out (Gebhard et al. 1990). 
Vitamin E, in its role as a potent 
antioxidant and immunostimulant, has received a great deal 
of attention (Tengerdy, 1990; Shor Posner et al. 1995; Liang 
et al. 1995; Finch & Turner, 1996; Liang & Watson, 1996). 
Vitamin E supplementation enhances humoral and cell- 
mediated immunity, and augments the efficiency of 
phagocytosis in laboratory animals and human subjects. 
Vitamin E deficiency has been suggested to contribute to 
alterations of the neonatal neutrophil function, and supple- 
mentation with 120 mgkg over the first 14 d of life of 
healthy premature infants has been shown to increase 
phagocytosis (Chirico et al. 1983). 
There is now increasing evidence that 
the hormonal form of vitamin D, 1,25-dihydroxycholeca1- 
ciferol (l,25(OH)2D3), is involved in the regulation of the 
7.2.2. Vitamin A. 
7.2.3. Vitamin C. 
7.2.4. Vitamin B complex. 
7.2.5. Vitamin E. 
7.2.6. Vitamin D. 
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immune system. 1,25(OH)2D3 exerts most of its actions 
after it has bound to its specific receptors which are present 
in monocytes and activated lymphocytes. The hormone 
inhibits lymphocyte proliferation and immunoglobulin 
production in a dose-dependent fashion. It interferes with 
T-helper cell function, reducing T-helper cell-induction of 
immunoglobulin production by B-cells and inhibits the 
passive transfer of cellular immunity by T-helper cells in 
vivo. Expression of Class I1 antigen by lymphocytes and 
monocytes is also affected. In experimental in vivo studies 
1 ,25(OH)2D3 is particularly effective in preventing auto- 
immune diseases (Schwartz, 1992; Mathieu et al. 1994; 
Thomasset, 1994). There is no information on the effects of 
vitamin D or its metabolites on the developing human 
immune system. 
7.3. Multiple micronutrient supplementation studies 
Trace elements perform important functions in growth and 
development. However, little information exists about diet- 
ary requirements of them during the demanding period of 
infancy. Although several factors influence the dietary 
needs of these essential elements, the basis for establishing 
dietary needs in infants is hindered by the dearth of studies 
that have assessed their bioavailability and effects on the 
immunity in this age group. Thus, until it has been con- 
clusively shown otherwise, the physiological response to 
human milk is used as the standard for infant feeding 
practices (Milner, 1990). 
Key questions such as the risks to human health of altered 
environmental distribution of Zn, assessment of Zn status in 
man, effects of Zn status in relation to other essential metals 
on immune function, reproduction, neurological function 
and others remain (Sherman, 1992; Walsh et al. 1994; 
Prasad, 1995; Ripa & Ripa, 1995; Sazawal et al. 1996). 
Zn supplementation has recently been shown to reduce 
persistent diarrhoea in children (Sazawal et al. 1996). 
In vitro and in vivo studies show that antioxidants gen- 
erally enhance different aspects of cellular and non-cellular 
immunity. The antioxidant function of these micronutrients 
could, at least in part, enhance immunity by maintaining the 
functional and structural integrity of important immune 
cells (Chew, 1995). 
Effects of trace minerals on the outcome of pregnancy 
have been reviewed. About 30 % of pregnant women suffer 
from Fe deficiency worldwide, and while its effects on 
neonatal Fe status are not severe, adverse sequelae include 
impaired neonatal immune status (Allen, 1986; for review, 
see Bryan & Stone, 1993). Low maternal intakes of Cu, Mn, 
and Se have not been associated with adverse outcomes of 
pregnancy. Se deficiency, however, appears to result in 
immunosuppression affecting neutrophil function, antibody 
production, cytotoxicity and lymphocyte proliferation 
(Kiremidjian Schumacher & Stotzky, 1987). 
7.4. Fatty acids 
Several lines of evidence support the role of dietary lipids as 
regulators of the immune system. This is demonstrated by 
studies examining lipid alteration of the immune response to 
allergens, malignancy, autoimmune disease, sepsis, trauma, 
and transplantation. Both the quantity and quality of lipid 
are important in immunoregulation. Both cell-mediated and 
humoral immunity are affected by dietary lipids. Multiple 
mechanisms probably contribute to the overall effects of 
lipids, including alteration of arachidonic acid metabolism, 
changes in cell membranes, production of inflammatory 
cytokines, and impairment of the reticuloendothelial 
system (Perez & Alexander, 1988; Yetiv, 1988; Fernandes 
et al. 1990; Melnik et al. 1991; Watanabe et al. 1994; 
Endres, 1996; Hellerstein et al. 1996). 
7.5. Arginine 
Many of the known roles of arginine (e.g. in immune 
function, wound healing, and protection against NH3 
intoxication) are mediated by a metabolic pathway synthe- 
sizing NO in the liver. Both stimulatory and suppressive 
functions have been identified with a prominent role of the 
macrophage (Barbul, 1990; Rodeberg et al. 1995; Suzuki et 
al. 1995; Krenger et al. 1996; Marcinkiewicz et al. 1996). 
Particular effects on the developing human immune system 
are uncertain. Oral administration may be less effective than 
parenteral administration (Torre et al. 1993). A number of 
reports investigate the potential benefits of arginine supple- 
mentation during surgical and other periods of stress in 
human subjects and in experimental models. Beneficial 
effects on wound healing, reduction of postoperative septi- 
caemias etc. cannot always be attributed entirely to arginine, 
since it was often given with other dietary modulations 
(Daly et al. 1990; Cerra et al. 1991; Seidman et al. 1991; 
Kemen et al. 1995; Senkal et al. 1995; Braga et al. 1996; 
Kudsk et al. 1996; Marcinkiewicz et al. 1996). 
7.6. Nucleotides 
Dietary sources of preformed purines and pyrimidines seem 
to be important for optimal function of the cellular immune 
response. It was previously assumed that nucleotides were 
not needed for normal growth and development, but the 
results described in the present review demonstrate a need 
for nucleotides in the response to immunological chal- 
lenges. The need for sources of preformed nucleotides in 
defined formulas such as parenteral and enteral formulas 
and infant formulas is suggested in some studies (Carver, 
1994; Kulkarni et al. 1994; Rudolph, 1994). An exogenous 
source of nucleotides from the diet may optimize the 
function of rapidly dividing tissues when growth is rapid 
and the diet is low in nucleotides. Studies performed in 
human infants are, at most, inconclusive (Carver, 1994; 
Kulkarni et al. 1994) and further studies are required to 
assess in infants the interesting findings about dietary 
nucleotides reported in experimental models (Gil & Uauy, 
1989; Sanchez Pozo et al. 1994, 1995; Ortega et al. 1995; 
Lopez-Navarro et al. 1996; Navarro et al. 1996). 
7.7. Maturation of the immune system in formula-fed v. 
breast-fed infants 
In a small study of systemic and secretory immunity of 
breast-milk-fed v. formula-fed infants it was shown that 
https://doi.org/10.1079/BJN19980104
Downloaded from https:/www.cambridge.org/core. IP address: 138.246.2.185, on 03 Mar 2017 at 16:07:24, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
S24 B. Koletzko et al. 
there is a general stimulation of responsiveness by cyto- 
kines in milk and a reduction of specific responses by 
antigen exclusion. Bottle-fed infants reached a similar level 
of immunological maturity by 3 months of age, exhibiting 
raised levels of serum antibodies against gut organisms and 
milk proteins and demonstrating increased non-specific 
activation of lymphoid cells (Stephens, 1986; Stephens et 
al. 1986a,b) 
7.7.1. Effects of antigen transfer via breast milk on the 
infant’s immunity. Dietary antigen excretion into breast 
milk seems to be a general phenomenon and has been 
reported for milk, egg, wheat proteins and parasite antigens 
(Kilshaw & Cant, 1984; Troncone et al. 1987; Petralanda et 
al. 1988). Excreted amounts are in the range of pgA. The 
immunological significance of transfer of dietary antigens 
during breast-feeding is still unclear. It is generally accepted 
that breast-feeding reduces the risk of food allergic reactions 
and also of atopy in a population at risk (uni- or biparental 
history of atopy) but sensitizing effects in infants have also 
been described (Warner, 1980; Gerrard & Shenassa, 1983; 
Savilahti et al. 1987; Lindfors & Enocksson, 1988). Studies 
by Chandra et al. (1986, 1989a), Zeiger et al. (1992) and 
others (Halken et al. 1993a; Vandenplas et al. 1995) suggest 
that elimination of (significant) dietary antigen transfer via 
breast milk for 6 months (amongst other preventive 
measures) in a population at risk reduces the probability 
of a food-specific sensitization (and possibly atopic 
symptoms) for up to 48 months, an effect which persists 
even after the diet of the infant has been liberalized. The 
following points merit special consideration. 
7.7.2. Maternal diet during pregnancy and effects on the 
infant’s immunity. There are no reports which demonstrate 
any preventive (or sensitization) effects in infants with a 
parental history of atopy (Fdth-Magnusson et al. 1987; Lilja et 
al. 1989; F4th-Magnusson & Kjellman, 1992). 
7.7.3. Maternal diet during pregnancy and lactation. In 
view of the complexity of the studies and the number of 
confounding variables, it is not entirely surprising that a 
number of studies have come to different conclusions. 
Maternal diet, while continuing breast-feeding, has been 
shown to be of moderate benefit in the reduction of atopic 
manifestations (mainly eczema) and milk allergy in infants 
or children (Chandra et al. 1989a,b; Sigurs et al. 1992; 
Zeiger et al. 1992; Zeiger & Heller, 1995). Other studies 
have failed to show this effect (Lilja et al. 1989). 
7.8. Role of the gut Jrora and probiotic bacteria in the 
infant’s immunity and gut defence 
Little is known about the immunomodulating capacity of 
the first bacteria colonizing the gut. Breast-fed infants 
develop a typical intestinal flora and this has been linked 
to a certain resistance to enteric infections. However, breast 
milk contains a host of other immunomodulating factors and 
it is difficult to claim any causality in these studies. Infants 
given breast-milk substitutes with various strains of lactic 
acid-producing bacteria may also exhibit some resistance to 
infections. In a small clinical study of thirty-nine children, 
protective effects of the supplementation of an infant for- 
mula with oligosaccharides, fermented milk or lactic acid- 
producing bacteria on the reduction of the incidence of acute 
diarrhoea were reported. A randomized controlled feeding 
trial with Bijidobacterium breve in ninety-one very-low- 
birth-weight infants demonstrated effective colonization, 
fewer abdominal signs and better weight gain (Kitajima et 
al. 1997). An enhancement of the circulating antibody- 
secreting cell response was observed in infants with rota- 
virus diarrhoea supplemented with a strain of Lactobacillus 
casei, compared with a placebo group (Kaila et al. 1992). 
The duration of this response and other protective or longer- 
term effects are unknown. Other small studies reported an 
enhancement in the phagocytic activity of granulocyte 
populations in the blood of human volunteers after con- 
sumption of fermented milk with Lactobacillus acidophilus 
and B. bi$dum (Schiffrin et al. 1995). It is unresolved 
whether studies in a larger number of unselected infants 
under different conditions in different countries would yield 
similar encouraging results. 
The gut microflora is an important constituent in the 
intestine’s defence barrier. Probiotic bacteria have been 
suggested to affect different aspects of gut defence: 
immune exclusion, immune elimination and immune 
regulation. 
7.8. I .  Immune exclusion and elimination. Although 
many clinical benefits have been ascribed to consumption of 
candidate probiotic strains in gastrointestinal disease 
(Isolauri et al. 1991; Saavedra et al. 1994), only a few 
human studies have assessed the effects of these bacteria on 
gut defence mechanisms. Early reports associated clinical 
observations with the effects on the intestinal microflora 
(Niv et al. 1963). Oral bacteriotherapy affected microbial 
imbalances shown during rotavirus infections in infants 
(Isolauri et al. 1994). Oral introduction of probiotic micro- 
organisms has been associated specifically with reduction of 
intestinal inflammation (Majamaa & Isolauri, 1997) and an 
increase in circulating antibody-secreting cells in the serum 
as an indicator of the intestine’s immunological barrier 
function (Kaila et al. 1992). In children with rotavirus 
diarrhoea, probiotic bacteria administered during the 
diarrhoea1 phase of the infection promoted clinical recovery 
and enhanced intestinal immunoglobulin A (IgA) responses 
(Kaila et al. 1992). 
7.9. Effects of formulas with protein hydrolysates on the 
infant’s immune responses 
Extensively hydrolysed casein formula has been used in the 
treatment of children with cow’s milk protein allergy andor 
intolerance. Recently, ultrafiltrated whey hydrolysates have 
been also been used therapeutically (Halken et al. 1993b). In 
an attempt to prevent andor modulate the risk of developing 
food-allergic and atopic manifestations in infants and chil- 
dren, less extensive (partial whey hydrolysates) (Chandra, 
1991; Vandenplas et al. 1992, 1995) and extensively hydro- 
lysed formulas (Chandra et al. 1989a; Zeiger et al. 1989; 
Halken et al. 1993a; Zeiger & Heller, 1995; Oldaeus et al. 
1997) have been used. Although these studies have been 
performed in infants of different (atopic) family and ethnic 
background, with different nutritional habits and different 
measures of control for confounding variables and a lack 
of standardized diagnostic protocols, they could be sum- 
marized as follows. (1) Infants with a high-risk family 
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background of atopic disease are likely to benefit from 
exclusive breast-feeding for 4-6 months with some added 
benefit if the mother avoids certain foods such as milk, eggs, 
fish and possibly nuts (including peanuts) during lactation. 
The benefits include a reduction in the incidence of cow’s 
milk and food allergies and atopic eczema for up to 4 years. 
(2) If exclusive breast-feeding for 4-6 months cannot be 
sustained, the use of a hydrolysed infant formula may help 
reduce the overall incidence of atopic manifestations in the 
child at risk. (3) Preventive effects of hydrolysed formulas 
in infants with a normal risk of developing atopic manifes- 
tations and the respective benefits of extensively v. less 
extensively hydrolysed infant formulas need to be further 
evaluated. 
7.10. Insulin-dependent type I diabetes mellitus and cow’s 
milk exposure in infancy 
Insulin-dependent diabetes mellitus (IDDM) is considered 
to be a chronic autoimmune disease characterized by 
gradual 0-cell destruction mediated by autoreactive T-lym- 
phocytes during an asymptomatic prediabetic phase of 
varying duration (Knip, 1992). In a Finnish study, associa- 
tions of infant feeding patterns and milk consumption with 
cow’s milk protein antibody titres were studied in newly- 
diagnosed diabetic children, sibling-control children and 
birth-date- and sex-matched population-based control 
children. Inverse correlations were observed between the 
duration of breast-feeding, or age at introduction of dairy 
products, and antibody titres. High IgA antibody titres to 
cow’s-milk formula were associated with a greater risk of 
IDDM both among diabetic-population-control and dia- 
betic-sibling-control pairs. The results suggested that 
young age at introduction of dairy products and high milk 
consumption during childhood increase the levels of cow’s 
milk antibodies and that high IgA antibodies to cow’s milk 
formula are independently associated with increased risk of 
IDDM (Vaarala et al. 1996). Similar associations between 
bovine serum albumin antibodies and onset of IDDM have 
also been found in a low-incidence French population (Levy 
Marchal et al. 1995). Human T-lymphocyte cultures of cells 
taken from affected children allowed the detection of bovine 
serum albumin-specific T-cells which were mapped to the 
ABBOS peptide (pre-bovine serum albumin position 
152- 169) previously identified as a possible immunological 
mimicry epitope which could explain the cross-reactivity 
with pancreatic islet cell antigens (Cheung et al. 1994). A 
currently ongoing prospective dietary intervention trial in 
children genetically at risk will be able to address the 
causality of this highly intriguing association and, it is 
hoped, open the way for a primary nutritional prevention 
strategy. 
8. Bone growth and mineralization 
8.1. Cell biology of bone growth 
Bone growth and mineralization is an ongoing process 
during human fetal and postnatal development, stabilizing 
at about 21 years of age. Skeletal Ca content increases from 
30 g in the neonate to 1200 g in the adult, and skeletal P 
from 17 to 700 g. Bone tissue possesses a series of enzymic 
mechanisms that permit mineralization of its extracellular 
matrix. This matrix is composed of collagen, proteoglycans 
and other non-collagen proteins in which insoluble mineral 
salts of hydroxyapatite and small amounts of other salts of 
Mg, sodium carbonate and citrate are deposited, converting 
it into a structure capable of supporting the organism. The 
two most important bone cell types are osteoblasts and 
osteoclasts. Osteoblasts are responsible for the formation 
and organization of the extracellular matrix and its subse- 
quent mineralization. Osteoclasts are large motile multi- 
nucleated cells, located on bone surfaces, responsible for the 
resorption of bone matrix. Bone growth or bone modelling 
is the result of two processes: first formation of new bone 
and then resorption to maintain the same structural form 
with, as a net result, acquisition of bone mass. At the age of 
about 18 years, both male and female adolescents have 
reached 95-99 % of their individual peak bone mass. After 
adolescence the processes of bone resorption and formation 
become quantitatively in balance and this situation is 
referred to as bone remodelling. After 35-40 years of age 
the processes of bone resorption and formation become 
uncoupled and net bone loss will occur, eventually leading 
to osteoporosis (Price et al. 1994; Anderson, 1996a,b). The 
obvious strategies to prevent, or at least delay, the onset of 
osteoporosis include: (a) optimizing the attainment of peak 
bone mass in adolescents, and (b) preventing bone loss in 
later life. 
8.2. Methodological aspects in bone-mass-related studies 
In the interpretation of the bone-mass-related results of the 
various studies one needs to be aware of the actual techni- 
que used. The first non-invasive methods for measuring 
bone mass were based on quantitative evaluation of standard 
radiographs. During the last decade gamma- or X-ray 
techniques were developed based on the variable effect of 
matter on the passage of radiation. Most studies were 
performed using either single photon absorptiometry 
(SPA) or dual-energy X-ray absorptiometry (DEXA). SPA 
is a relatively simple technique using ‘’1 as the radioactive 
source. Its application is limited to the peripheral skeleton, 
particularly the radius. DEXA is becoming more and more 
the preferred technique to assess bone density at various 
sites of the skeleton with only minimal radiation exposure. 
Although calibration of DEXA instruments seems to be a 
rather trivial exercise, it relies strongly on highly specific 
software, with the results that measurements on one patient 
made with instruments of different brands do not necessarily 
result in similar bone mineral density data (Slosman et al. 
1995). An additional feature of DEXA is its ability to 
measure whole-body mineral content as well as body 
composition. Appropriate DEXA software for infants has 
been developed recently and reference values from the first 
studies are now beginning to become available in the 
literature (Rigo et al. 1996). The fact that SPA and DEXA 
data cannot be compared with each other is illustrated by the 
fact that SPA produces a measurement of bone mineral 
content (g/cm) and assumes that the site of measurement is a 
small cylinder of constant width, whereas DEXA produces a 
measurement of bone mineral density (g/cm2) by correcting 
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Table 1. Additional increment in bone mineral density (BMD) (as a percentage) following supplementation of the diet with calcium or dairy 
products, in children and adolescents from five different studies (From Kerstetter, 1995) 
Johnston eta/. (1992)* 
Prepubertal Pubertal Lloyd et a/. (1 993) Lee et a/. (1 994) Andon et a/. 1994)t Chan et a/. (1 995) 
Subject no., total 22 twin pairs 23 twin pairs 94 162 248 48 
Sex Boys and Boys and Girls Boys and Girls Girls 
girls girls girls 
Entry age (years) 6.9 (SD 1.4) 10.6 (SD 2.0) 11.9 (SD 0.5) 7.2 (SD 0.2) 1 1.4 (SD 0.8) 11.1 (SO 1.0) 
Intervention duration (months) 36 18 18 6 12 
Baseline Ca intake (mg/d) 908 935 280 888 728 
Total Ca intake (mg/d) 1612 1370 580 1315 1618 1437 
Supplemental Ca source Ca citrate malate Ca citrate malate CaCO, Ca citrate malate Dairy foods 
BMD determination DEXA DEXA SPA DEXA DEXA 
Change in BMDS 
(placebo) 
(diet + supplement) 
Midshafl radius +5.1 -0.1 
Distal radius +3.8 +2.9 +3.1 NS 
Lumbar spine +2.8 -1 .o +2.9 +9.9 
Femoral neck +1.2 -0.4 NS 
Ward’s triangle +2.9 -0.4 
Greater trochanter +3.5 +0.2 
Total body +1.3 +1.0 +2.2 +6.6 
DEXA, dual-energy X-ray absorptiometry; SPA, single photon absorptiometry. 
*Two age groups were studied: prepubescent (6.9 (SD1.4) years) and pubescent (10.6 (~~2.0) years). 
t Two levels of dietary Ca (1 31 5 and 161 8 mg/d) were studied. 
$Change in BMD = percentage increase in supplemented group minus increase in unsupplemented group. 
the bone mineral content for the projected area of bone 
(Slosman et al. 1995). A shortcoming of the usual expres- 
sion of bone mineral density obtained by DEXA (g/cm2) is 
that this areal bone mineral density does not take the age- 
related increase in bone thickness into account. Therefore 
Cowell et al. (1995) have developed a measure of true bone 
mineral density, volumetric bone mineral density (g/cm3), and 
demonstrated its usefulness in assesssing patients with phen- 
ylketonurea (PKU), chronic renal failure and chronic asthma. 
8.3. Peak bone mass and relative risk of osteoporosis 
The relative importance of peak bone mass on the subse- 
quent risk of osteoporosis has recently been reviewed by 
Ribot et al. (1995). They started with the available in vitro 
evidence on the relationship between low bone mass and the 
risk of osteoporosis relating to the mechanical properties of 
bone. The relevant in vivo studies include both cross- 
sectional surveys and at least eleven prospective studies. 
From these studies it can be deduced that the relative risk of 
osteoporosis for each 1 SD decrease in bone mineral density 
is increased by a factor of between 1.7 and 2.7. On 
comparing this value with the relative risk of CHD for a 1 
SD rise in serum cholesterol or that of stroke for 1 SD 
increase in blood pressure being 2.1 and 1.3 respectively, 
it is clear that low peak bone mass is a very strong risk factor 
for later osteoporosis. Another appealing value relating to 
the relevance of optimizing or increasing peak bone mass 
can be deduced from the study by Gilsanz et al. (1991) on 
comparing the development in peak bone mass in white and 
black girls. They found a 10-20 % higher bone density in 
black girls relative to white girls which is likely to corre- 
spond to an additional 10-20 years of protection against the 
decline in skeletal mass, and might explain the relatively 
low prevalence of osteoporosis in black women. About 80 % 
of the variance in bone mineral density is accounted for by 
genetic factors (Pocock et al. 1987), thus leaving only 20 % 
of the variance to be influenced by environmental factors 
such as diet. For this reason the investigation of twin pairs is 
very attractive because the genetic bias may thus be minim- 
ized (Johnston et al. 1992). From a study with postmeno- 
pausal twins in Britain, Spencer et al. (1995) reported a 
genetic linkage between the vitamin D receptor genotypes 
and bone mineral density. The degree to which this might 
explain the genetic factors is as yet unclear and a recent study 
from Denmark failed to find any significant association 
between common allelic variations at the vitamin D receptor 
locus and bone mineral density (Jargensen et al. 1996). 
8.4. Bone growth and mineralization in infants and young 
children 
The literature on the effects of different diets during infancy 
on bone mineral content at 2 or 5 years of age is not yet 
consistent. Exclusive feeding of breast milk during the first 
6 months of life supports a bone growth considered adequate 
even though breast milk contents of Ca and vitamin D are 
relatively low. Infant formulas in general, and formulas for 
premature infants in particular, contain higher levels of 
these nutrients to meet the dietary requirements and to 
provide a safety margin to correct for a likely lower 
bioavailability. Surprisingly, Bishop et al. (1995) reported 
a strong positive association between the amount of human 
milk consumed and bone mineral content at the age of 5 
years in their multi-centre cohort of prematurely born 
infants. The authors raised two possible hypotheses to 
interpret their finding. Bone mineral depletion in preterm 
infants fed on unsupplemented human milk might 
‘programme’ these infants to be conservative with bone 
mineral and to reduce the overall rate of growth so that 
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‘over-mineralization’ occurs at a later stage when the intake 
of bone mineral substrates is normal. A second possibility is 
that one or more of the human milk growth factors might 
survive breast milk pasteurization and the immature diges- 
tion system and end up via the circulation at the target 
organ. Until one of these hypothetical mechanisms is further 
substantiated, the general goal in the nutrition of premature 
infants remains to provide enough mineral supplementation 
to allow attainment of bone mineral content comparable to 
that accrued in utero and to support catch-up growth in the 
first year of life. Several studies comparing bone miner- 
alization in term-born breast-fed infants with that in infants 
fed on formulas containing moderate or high Ca content 
conclude that the bone mineral content of formula-fed 
infants is higher at the ages of 2 and 5 years (Demirini & 
Tsang, 1995). Whether this effect of cumulative Ca intake 
during the first 2 years of life will be retained until 
adolescence is still unclear. A negative impact on bone 
growth and mineralization has been reported for a number 
of chronic conditions during infancy and early childhood 
like cystic fibrosis, IDDM, cerebral palsy, leukaemia, renal 
disease, growth hormone deficiency and anorexia nervosa 
(Shaw & Bishop, 1995). In a group of fifty-five children 
with milk allergy showing a broad distribution of daily Ca 
intake (quartiles: 409, 663, 950 and 1437 mg Cdd), a clear 
correlation was found between Ca intake and bone mineral 
density, thus underlining the vulnerability of this group and 
illustrating the efficacy of dietary measures or supple- 
mentation of Ca to achieve normal bone growth (Henderson 
& Hayes, 1994). 
8.5. Calcium supplementation in children and adolescents 
and bone health 
Despite the relatively poor contribution diet is supposed to 
make to the variance of peak bone density, a substantial 
number of studies have been published in recent years to 
address the effects of nutrition, particularly of Ca, on bone 
density in children and adolescents. These studies have 
been reviewed by Kerstetter (1995) who concluded that 
the cross-sectional and correlation studies have yielded 
rather mixed results. Surprisingly, more consistent findings 
were obtained from the five recent prospective Ca or dairy 
supplementation studies in children and adolescents pub- 
lished between 1992 and 1995. In Table 1 the basic data 
from these studies (Johnston et al. 1992; Lloyd et al. 1993; 
Andon et al. 1994; Lee et al. 1994; Chan et al. 1995) are 
compared. In all studies the baseline Ca intake was less than 
1000 mg/d and the amount of supplemented Ca ranged from 
300 to 700mg/d. The percentage increase in bone mineral 
density in all the supplemented groups amounted to 1 - 10 % 
and was significant in all studies. Of those intervention 
studies, the one by Chan et al. (1995) is most appealing 
because in this study a near doubling of the Ca intake (from 
728 to 1437mg/d) was reached only by supplementation 
with dairy products and the increase in total body bone 
mineral density amounted to 7 %. However, the conclusion 
which one might draw on superficial reading of the review 
by Kerstetter (1995) that dairy products outperform other Ca 
supplements cannot be substantiated yet. Nevertheless, it is 
remarkable that in the study by Chan et al. (1995) the 
supplemented dairy products also contained some vitamin D 
and extra P, which can at least be interpreted as showing that 
P has no negative effect on peak bone mass accretion in 
adolescents under these conditions. In conclusion, the 
results from the Ca and dairy-product supplementation 
studies summarized have clearly demonstrate that it is 
possible to increase peak bone mass at the end of adoles- 
cence simply by dietary means. 
8.6. Nutrients other than calcium and environmental factors 
involved in bone growth 
The crystal salt of bone resembles hydroxyapatite 
(Calo(PO,),(OH),) which contains Ca and P in the propor- 
tion 2.15: 1 (w/w); in addition approximately 60 % of the 
body Mg and 30% of the body Zn are present in the 
skeleton. It is, therefore, obvious that P, Mg and Zn are 
also important nutrients in the process of bone mineraliza- 
tion. Although there is little information about conditions in 
developed countries where Mg or Zn would represent single 
limiting factors causing impaired bone growth, it seems 
reasonable and prudent to include these elements propor- 
tionally in supplements, possibly also taking their different 
rates of absorption into account. The case for P is more 
delicate and, except for premature infants where P intake 
can be a limiting factor for bone growth, much more 
concern has been shown about excessive dietary intakes of 
P (Calvo & Park, 1996). High P intake results in an 
increased serum P concentration which initiates several 
hormonal respones, of which an increase in parathyroid 
hormone level effects the balance between bone mineraliza- 
tion and bone resorption (Anderson, 1996a,b). It is for this 
reason that in several supplementation studies no phosphate 
was given in order to shift the Ca : P ratio as much as 
possible in the direction of Ca. As already mentioned, the 
results from the study by Chan et al. (1995) give support to a 
concept where the absolute amount of Ca is more important 
than the Ca : P ratio. 
A nutrient which is most important in bone metabolism is 
vitamin D. The major role of dietary vitamin D is to function 
as precursor for 25-hydroxy- and 1,25-dihydroxycholeca1- 
ciferol which maintain the plasma Ca concentration within 
very narrow limits. This is accomplished by varying the 
proportion of dietary Ca absorbed and excreted. As the body 
becomes vitamin D depleted, the efficiency of Ca absorption 
decreases from 30-50 % to no more than 15 %. In addition, 
1,25-dihydroxycholecalciferol has a direct effect on osteo- 
blast production and thus on bone formation and miner- 
alization (Anderson, 1996a,b). The major source for vitamin 
D in human subjects is exposure to sunlight which enables 
cutaneous synthesis of vitamin D. However, several groups 
ranging from premature infants to institutionalized elderly 
people may not be able to receive sufficient exposure to 
sunlight and thus require dietary vitamin D. 
The involvement of vitamin K in bone metabolism is 
through its action on maturation of osteoblastic bone pro- 
teins by carboxylation of their glutamate residues (Vermeer 
et al. 1996). Vitamin K may be generated by the intestinal 
microflora or obtained from dietary sources such as green 
vegetables and meat. Except for the fact that it depends on 
the quantity of fluoride ingested and the time of exposure, 
https://doi.org/10.1079/BJN19980104
Downloaded from https:/www.cambridge.org/core. IP address: 138.246.2.185, on 03 Mar 2017 at 16:07:24, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
S28 B. Koletzko et al. 
the role of F in bone health is still poorly understood. It has 
been used as a therapeutic agent in bone pathology includ- 
ing osteoporosis, but also cases of skeletal fluorosis are 
reported with radiologically demonstrable abnormal bone 
densification (Boivin et al. 1993). Of the minerals for which 
a role andor essentiality in man is still unclear, B has been 
connected with the mechanical properties of bone 
(Mastrmatteo & Sullivan, 1994). Because the effects of B 
supplementation are not striking, and plausible mechanistic 
explanations still need to be presented, it is uncertain 
whether B will become an important issue in bone health 
research. In a cross-sectional study in about 500 children 
and adolescents (aged 8-17 years) bone mineral density was 
found to be related to diet, weight-bearing exercise and 
daylight hours spent outdoors (Gunnes & Lehman, 1995). 
Next to an effect in accordance with the literature with 
respect to dietary Ca it is surprising that the authors found a 
positive correlation between bone mineral density and 
saturated fat, fibre and vitamin C. Any interpretation of 
these correlations can only be speculative. The positive 
association between fat intake and bone mineral density 
might be attributed to an increased intake of vitamin D with 
the fat or might possibly be mediated by a higher cholesterol 
level. The positive association between bone mineral den- 
sity and fibre intake is even more puzzling because one 
might expect exactly the opposite based on impairment of 
Ca absorption by dietary fibre. As a possible explanation for 
the association between vitamin C and bone mineral den- 
sity, the authors indicate the fact that vitamin C is a cofactor 
in collagen synthesis. Moreover, they point to a possible 
link between high intakes of Ca, fibre and vitamin C as 
constituents of a more wholesome diet. Considering the 
importance of a high Ca intake in achieving maximal bone 
growth and peak bone mass, it seems logical to prevent any 
negative dietary interactions which might interfere with 
maximal Ca absorption. Of the dietary interactions affecting 
Ca absorption reviewed by Licata (1993), the possible 
negative effect of caffeine is mentioned because it increases 
urinary Ca excretion. However, this effect is considered to be 
fairly unimportant relative to other factors and is also not 
consistently found in all the studies. A clear negative effect 
on Ca absorption is represented by dietary oxalate-exem- 
plified by the poor Ca absorption (only 5 %) from oxalate- 
rich spinach. Although some authors report a stimulating 
effect of lactose on Ca absorption in humans, others fail to 
find any significant effect. Essentially the same holds true 
for the effect of protein on Ca absorption: if there is any 
stimulating effect, it will be rather small. In view of the 
marginal gain on fractional Ca absorption which can possibly 
be obtained by optimizing the nutritional matrix, selecting Ca 
salts with a high bioavailability may be of particular rele- 
vance. In this respect an increase in fractional Ca absorption 
of 0.26 to 0.36 which can be achieved by replacing CaC03 
with calcium citrate-malate is illustrative (Peacock, 199 1). 
9. Nutrient effects on development of neural functions 
and behaviour 
9.1. Introduction 
Pregnancy and the first postnatal months are critical time 
periods for the growth, development and differentiation of 
the human nervous system. There is good evidence that 
availability of nutrients during these critical time periods 
affects brain growth and development and can have long- 
term programming effects on an individual’s central ner- 
vous functions. In contrast to some other mammalian 
species, in man the peak growth rate of the brain (‘brain 
growth spurt’) occurs both pre- and postnatally, with con- 
tinued relatively rapid growth well into the second year of 
life. Between the 24th week of gestation and the time of 
term birth, brain weight increases more than fivefold. The 
disproportionate speed of brain growth, compared with total 
body growth, is apparent from the fact that at age 2 years the 
weight of the human brain has already reached 80 % of adult 
weight, while whole body weight at this age is less than 
18 % of adult weight. An adequate substrate supply is 
essential for a physiological brain composition and differ- 
entiation during this rapid perinatal growth. 
9.2. Physiology of neural development 
Development of neuronal tissues is characterized by the 
sequential occurrence of mitosis, cell migration, differentia- 
tion, synaptogenesis, apoptosis and synaptic reorganization. 
These consecutive steps begin during pregnancy at different 
gestational ages and occur over a certain time period in 
different brain areas; therefore, there is an overlap in time of 
the various brain development steps in different areas of the 
brain (Reisbick, 1996). 
Mitosis of germinal cells located along the neural tube 
and the brain ventricles, which form neuronal and glia cells, 
begins in the sixth embryonic week, peaks in the second 
trimester and is almost complete by the end of the second 
trimester, even though a small number of cells may form 
during the last trimester of gestation (Jacobson, 1991; 
Rakic, 1995). Under the influence of hormones, cell adhe- 
sion molecules and other local factors, the created cells 
migrate to the brain nuclei and cortex and the ganglia of the 
peripheral nervous system (Jacobson, 1991; Kandel et al. 
1991). Although largely occumng during pregnancy, ner- 
vous cell migration particularly in the superficial layers of 
the cerebral and cerebellar cortices continues to occur after 
term birth (Rakic, 1995). Cell differentiation into particular 
neurons may begin during migration but generally is only 
completed at its final destination (Kandel et al. 1995). The 
differentiation of neuronal cells is modulated by induction 
through surrounding cells, the kind of cell innervated, 
growth factors and hormones such as glucocorticoids, and 
nutrient intakes. For example, pre- and postnatal protein- 
energy malnutrition has marked effects on brain cell 
differentiation (Cravioto & Cravioto, 1996), and long-term 
depletion of the 12-3 PUFA DHA induced altered brain cell 
levels of monoamines and monoamine receptors in rats. 
When neurons have migrated to their destination and 
reached their differentiation, they grow and form synaptic 
connections (Kandel et al. 1995). Most cell growth in the 
human cerebellar cortex occurs between 32 weeks of 
gestation and 11 months after term birth (Rakic, 1995). 
Synaptogenesis in primates peaks in the first 2-3 months of 
life (Rakic, 1995), and the number of synapses in the human 
visual cortex increases twofold between the ages of 2 and 8 
months after birth, which is paralleled by a marked increase 
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in the number of neurotransmitter receptors (Huttenlocher et 
al. 1982). The number of synapses formed is far greater than 
the number of synapses later found in adult brains. The early 
rapid synaptogenesis depends on an extensive formation of 
highly fluid cell membranes and, hence, on sufficient avail- 
ability of substrates required for this membrane formation. 
Brain structure and function is also greatly influenced by 
apoptosis, since cell death affects between 20 and 80 % of 
the neuronal cells formed during gestation before the time of 
birth (Rosenzweig et al. 1996), which appears to be 
regulated by genetically programmed apoptosis, protecting 
neurotrophic factors, synaptogenesis, hormones and 
eicosanoids. In the surviving cells, the synaptic connections 
are reduced and rearranged at a rapid rate initially, but 
continuing throughout the life of the organism in relation to 
stimulation and learning. This synaptic rearrangement 
appears to be regulated by many different modulators, 
including Ca channels, second messengers such as phos- 
phatidyl inositol, protein kinases, membrane lipids and 
eicosanoid hormones (Reisbick, 1996; Wainwright, 1997). 
9.3. Nutrition and neural development 
In Europe and other developed countries, an associated 
secular increase both of adult height and adult intelligence 
quotients has been observed over the last few decades, and 
the hypothesis has been raised that both these effects are 
related to the early nutrient supply. 
Several studies have documented that severe general 
malnutrition in infancy or early childhood, which is 
characterized by a combined deficiency of energy, protein 
and many other substrates, is associated with a marked 
reduction of cognitive ability (Cravioto & Cravioto, 1996; 
Kretchmer et al. 1996). However, the adverse effects on 
neural development cannot be attributed entirely to nutrient 
depletion, but may also be modulated by other factors 
typically associated with severe childhood malnutrition, 
including infections, poverty, psychological depression 
and lack of adequate stimulation. Evidence of organic 
effects of malnutrition on brain growth and maturation 
was provided by the demonstration of cerebral atrophy 
and lasting organic brain damage (Ambrosius, 1966; Stoch 
et al. 1982; Houscham & Devilliers, 1987) and by electro- 
physiological evidence of impaired information processing, 
such as altered auditory evoked brain stem potentials 
(Barnett et al. 1978; Bartel et al. 1986). 
9.3.1. Protein. Randomized studies in premature 
infants demonstrated that a low protein intake during the 
early postnatal period resulted in poorer results of orienta- 
tion, habituation and stability clusters when tested with the 
neonatal behaviour assessment scale (Bhatia et al. 1991), 
and in a markedly reduced mental and psychomotor 
development when assessed at an age of 18 months post- 
term with the Bayley scales of infant development (Morley 
& Lucas, 1993). 
9.3.2. Iodine. Today I deficiency is considered the 
most common cause of nongenetic inborn neurological 
damage on a worldwide basis, and causes cretinism with 
severe mental retardation (Stanbury, 1994). In I-deficient 
populations, an early I supply beginning before or at the 
time of conception can prevent neural damage of the infant, 
whereas a later start of I supply in the second or third 
trimester of pregnancy or after birth is associated with a 
smaller preventive effect (Xue-Yi et al. 1994). 
9.3.3. Iron. Fe uptake into the brain is mediated by 
transferrin receptors on the endothelial surface of brain 
microvasculature, reaches its maximum during the period of 
rapid brain growth and peak myelinogenesis (Taylor & 
Morgan, 1990) and continues throughout life. Analysis of 
Fe distribution in the human brain during childhood with 
magnetic resonance imaging showed the highest concentra- 
tions in the globus pallidus, caudate nucleus, putamen and 
substancia nigra, while the cortex and cerebellum had 
substantially lower contents. Fe serves as an essential 
cofactor in a variety of cellular and metabolic functions, 
including the synthesis of dopamine, serotonin, catechola- 
mines and possibly y-aminobutyric acid as well as myelin 
formation (Kretchmer et al. 1996), while Fe overload has 
toxic effects. In young rats deprived of Fe in early postnatal 
life, total brain Fe content was severely depleted to 27 % of 
that of controls and was resistant to later restoration despite 
aggressive treatment (Dallman & Spirito, 1977). Sustained 
early Fe deficiency in rats causes persistent behavioural and 
learning deficits, leading to the hypothesis that Fe 
sufficiency throughout the critical phases of early brain 
development is crucial to the achievement of normal brain 
Fe content, function and behaviour. Several studies in 
children have clearly documented that severe Fe depletion 
resulting in Fe-deficiency anaemia results in a poor attention 
span, poor performance in the Bayley mental development 
index, low intelligence scores, some degree of perceptual 
disturbance and altered affective behaviour (Lozoff & 
Brittenham, 1986; Beard et al. 1993; Pollitt, 1993; Sheard, 
1994; Kretchmer et al. 1996). Although children with Fe 
depletion without anaemia also showed behavioural 
abnormalities in some studies, these abnormalities appear 
to have been influenced by poor environmental conditions 
that were associated with the occurrence of Fe depletion 
(Lozoff et al. 1996). At this time there is no conclusive 
evidence that poor Fe status without anaemia has adverse 
effects on neural development in children. 
9.3.4. Zinc. In animal experiments, Zn deprivation 
was shown to adversely affect brain growth, learning ability, 
memory and activity (Smart, 1974; Halas & Sanstead, 1975, 
1980; Peters, 1979). Low-birth-weight infants showed an 
improvement of motor development when supplemented 
with Zn (Friel et al. 1993). In a recent study in Indian 
children aged 6-35 months who were not malnourished, 
daily supplementation with lOmg elemental Zn (as Zn 
gluconate) for a period of 6 months resulted in a significant 
increase of observed activity (Sazawal et al. 1996). 
9.3.5. Polyunsaturated fatty acids. Some 50-60 % of 
the structural matter in the central nervous system is 
composed of lipids, which almost entirely serve structural 
functions in cell membranes and myelin. Much of the rapid 
lipid accretion during brain growth comprises lipids that can 
be synthesized de novo in the fetus and infant, e.g. 
cholesterol. In addition, the rapid brain growth occurring 
perinatally and the extensive synaptogenesis occurring 
during the first months of life require the incorporation of 
relatively large amounts of essential PUFA, primarily the 
highly unsaturated long-chain PUFA DHA and arachidonic 
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acid (Koletzko, 1992). In experimental studies, the addition 
of DHA and arachidonic acid to fetal mouse brain cultures 
increased the number, diversity and complexity of synaptic 
contacts (Tixier-Vidal et al. 1986). In addition to cell 
growth and synaptogenesis, long-chain PUFA as well as 
eicosanoids formed from long-chain PUFA may influence 
neural cell apoptosis (Finstad et al. 1994; Wainwright, 1997). 
Experimental studies in rodents and in non-human primates 
indicated that the degree of long-chain PUFA incorporation 
into the developing brain influenced reflex development, 
memory, discrimination learning, retinal function and visual 
acuity (Neuringer, 1993; Wainwright, 1993), i.e. functions 
related to the efficacy of information processing. 
The human fetal supply with preformed long-chain PUFA 
by a materno-fetal placental transfer (Koletzko & Muller, 
1990) may be influenced by the maternal dietary long-chain 
PUFA intake. Also, the postnatal long-chain PUFA supply 
in human milk is affected by maternal diet and can be 
altered by dietary supplements provided to lactating women 
(Harris et al. 1984; Koletzko et al. 1992). In contrast to 
human milk, most infant formulas do not contain preformed 
DHA and arachidonic acid. Although newborn infants have 
the ability to synthesize long-chain PUFA from EFA 
precursors, the rate of synthesis appears to be low 
(Demmelmair et al. 1995; Sauerwald et al. 1997) and 
long-chain PUFA levels in blood lipids (Decsi & Koletzko, 
1995) and brain (Farquharson et al. 1992; Makrides et al. 
1994) of formula-fed infants are significantly lower than 
those found in breast-fed infants. 
Some randomized intervention studies comparing diets 
without and with a supply of preformed long-chain PUFA 
both in premature infants (Uauy et al. 1990; Carlson & 
Werkman, 1996) and in healthy term infants (Makrides et 
al. 1993, 1995; Agostoni et al. 1995) found indications of 
improved retinal and visual function and of cognitive 
development in infants receiving long-chain PUFA, while 
other studies found no appreciable advantage (Innis et al. 
1996). Effects of supplementing additional long-chain 
PUFA during pregnancy or lactation on functional devel- 
opment of the infant have not been reported. 
9.4. Early nutrition and development of taste preferences 
Preferences of taste and smell are critical factors in selecting 
foods and drinks throughout life. There are some indications 
that sensory perception of tastes and flavours may be 
modulated by early exposure. 
Observations of fetal swallowing following the ingestion 
of sweet- and bitter-tasting substances into the amniotic 
fluid suggest that the fetus is sensitive to sweet- and bitter- 
tasting substances (de Snoo, 1937; Liley, 1972). It has been 
concluded that both the olfactory apparatus and taste per- 
ception are fully developed in utero (Beauchamp et al. 
1991). Molecules carrying flavours and aromas may cross 
the placenta, and it has been proposed that early sensory 
exposure may modulate the acquisition of later flavour 
preferences. In animal studies, such effects of intrauterine 
exposure to flavour-rich foods on postnatal food choices 
have been documented. 
Premature infants tested between 33 and 40 weeks post- 
conception and newborns during the first hours after birth 
show a clear and reproducible preference for sweet tastes 
(Beauchamp & Mennella, 1980). In blinded controlled 
studies, the sucking behaviour of breast-fed infants is 
altered by supplementing their mothers with encapsulated 
garlic compared with placebo, and repeated consumption of 
garlic modifies the infantile response to this taste (Menella 
& Beauchamp, 1993). Also the volatile flavours of vanilla 
and alcohol modulate infantile sucking behaviour 
(Beauchamp & Mennella, 1980; Mennella & Beauchamp, 
1991). The question of to what extent food choices during 
childhood and adult life are modulated by pre- and postnatal 
experience is of major importance and needs to be further 
explored. 
9.5. Methodological aspects 
An optimization of the quality of nutrient intakes during 
pregnancy, lactation and infancy may well have the poten- 
tial of improving developmental outcomes in the recipient 
infants. Since even small improvements of the population 
means by such potential effects are of major public health 
significance, they need to be carefully examined. If plaus- 
ible hypotheses can be raised and supported by data from 
experimental models, epidemiological studies or pilot inter- 
vention trials, they should be subjected to rigorous testing 
with adequate scientific methodology in double-blind 
placebo-controlled randomized trials. While some electro- 
physiological measures of human neural function can be 
assessed with sufficient precision to justify interventions in 
small groups, behavioural methods tend to have a greater 
degree of variation and, therefore, effects on such outcome 
variables require large studies, particularly if one considers 
that dietary factors must be expected to have relatively small 
effects compared with genetic and other environmental 
influences. The results of such studies can be greatly 
influenced by the study design and factors such as the 
time points chosen for testing effects as well as the ade- 
quacy of the method chosen for testing the targeted effect. 
Large sample sizes may be required, for example, to show 
an effect of a dietary supplement, resulting in a comparably 
small mean difference of developmental scores due to the 
many other variables that influence such end-points. There- 
fore, the realization of adequate trials to test for long-term 
developmental effects of early food choices will usually 
require a large budget. In view of the major public health 
importance of the questions addressed by such trials, it 
appears justified that well-designed trials addressing rele- 
vant and pertinent questions are supported by public funds. 
10. Production of bioactive factors for inclusion into food 
products 
Interest in the production of human milk proteins, peptides, 
growth factors and other bioactive substances with the use 
of biotechnology and recombinant techniques is growing. 
The inclusion of such substances into dietary products may 
have beneficial physiological effects particularly in infancy 
and early childhood, for example defence against infectious 
agents, the optimization of nutrient uptake from the diet as 
well as the differentiation and growth of cells and tissues. 
Micro-organisms and transgenic animals can now be used 
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for the production of bioactive proteins (Lonnerdal, 1996). 
However, the benefits and safety of each substance must be 
evaluated in adequate studies in cells, animal models and 
clinical studies before routinely adding them to products for 
infants to improve their nutrition, health or development. 
Proper manufacturing conditions must be developed for 
introducing such substances into foods. The importance of 
post-translational modifications must also be taken into 
account. Some proteins may require proper glycosylation 
or phosphorylation for physiological activity. 
Several human milk proteins have been cloned and 
sequenced. The majority were cloned at the level of 
complementary DNA (cDNA). In a few cases the entire 
gene has been characterized. One of the first milk proteins 
which was cloned from a mammary gland library was a- 
lactalbumin (Hall et al. 1987). Other human milk proteins 
that have been cloned include lysozyme, lactoferrin, 
human P-casein and K-casein. For the production of 
human milk proteins and bioactive factors, several expres- 
sion systems can be used, such as bacterial expression of 
recombinant proteins. The expression vector can be con- 
structed so that the protein is made available in the super- 
natant fraction or in the bacteria. Bacterial expression will 
lead to the production of proteins which are not phos- 
phorylated or glycosylated. If this property is needed for 
biological functions, yeast or fungi can be used as expres- 
sion systems. Saccharomyces cerevisiae was used to pro- 
duce human lactofemn (Liang & Richardson, 1993) and 
human &caseins. Asperg illus nidulans and Aspergillus 
oryzae were also used to produce human lactofemn 
(Ward et al. 1992a,b). Alternatively, living cells such as 
baby hamster kidney cell can be used to produce human 
lactofemn (Ward et al. 1992~).  As such expression sys- 
tems will still provide proteins with different phos- 
phorylation and glycosylation, physiological function 
may be altered. Tissue-specific expression of human 
milk proteins in transgenic animals should result in 
recombinant protein glycosylations and phosphorylation 
similar to the native human milk proteins. 
The architecture of the transgene DNA that is introduced 
into the germline of animals by microinjection plays an 
important role in the level of expression of the transgene. 
DNA that is introduced by microinjection into the pro- 
nucleus is usually inserted randomly into the genome as 
head-to-tail concatemers. Because the eukaryotic genome is 
organized into topologically constrained domains, random 
integration can lead to position effects in which the trans- 
gene expression is influenced by the surrounding chromo- 
somal sequences. Thus in many cases the level of transgene 
expression will vary over several logarithms, depending on 
the site of integration, and expression may be observed in 
<50% of the positive transgenic mice. Because of the 
expense and time required to generate transgenic livestock, 
this presents a major problem (Stowell et al. 1991). To date, 
human lactoferrin (Rosen et al. 1996) and human lysozyme 
(Kim et al. 1994) have been expressed in transgenic mice 
with reasonable expression in the milk. Human lactoferrin 
was recently produced in transgenic cows (Maga et al. 
1994). Whether the glycosylation pattern of human lacto- 
ferrin within the cow’s mammary cells will alter the 
biological function remains to be elucidated. 
Similar to the gene farming of human milk proteins and 
other important functional proteins in transgenic animals, 
such bioreactors are used to produce human hormones and 
growth factors. In transgenic rabbits, hGH was produced in 
milk in suitable amounts without being affected by the 
transgene expression (Limonta et al. 1995). Bovine 
growth hormone was also placed by a recombinant techni- 
que into the milk of transgenic mice (ThCpot et al. 1995). In 
addition, human IGFl was expressed in the milk of trans- 
genic mice (Hadsell et al. 1996) and rabbits (Brem et al. 
1994). Some oligosaccharides which may play an important 
role in promoting growth and differentiation of intestinal 
epithelial cells have successfully been expressed in the milk 
of transgenic mice (Prieto et al. 1995). The enormous 
potential of these methodologies for improving food prod- 
ucts needs to be further explored. 
11. Commentary on biomarkers 
Drawing on experience from child health and development 
it is possible to use experience of inborn errors of metabol- 
ism to demonstrate the evolution and use of biomarkers to 
detect and predict a disease arising from an imbalance 
between systemic homeostasis and essential and non-essen- 
tial dietary components. A good example is hyperphenyl- 
alaninaemia (HPA) which arises from an inborn error of 
metabolism of the essential amino acid phenylalanine 
(Scriver & Clow, 1980; Guttler, 1984). First of all, however, 
it is helpful to consider some general aspects of the strategy 
of biomarkers. 
Biomarkers can be defined as indicators of actual or 
possible changes of systemic, organ, tissue, cellular and 
sub-cellular structural and functional integrity which can be 
used, either singly or in batteries, to monitor health and 
exposure to compounds in populations and individuals: as 
such they are the essence of chemical pathology or clinical 
biochemistry. Thus although the term ‘biomarker’ might 
itself be relatively novel, the concept is far from being so: 
the use of biochemical biomarkers dates at least from the 
discriminatory use of the sweet taste of glycosuria to 
diagnose and name diabetes mellitus. This intolerance of 
glucose illustrates a disturbance of the usually tightly 
controlled internal milieu as conceived by Claude Bernard, 
and of the processes involved in maintaining this state, i.e. 
homeostasis. These mechanisms lie at the core of the 
regulatory adaptations which maintain a steady state in the 
face of changes in environment, including our interaction 
with desirable and non-desirable components of the diet, 
which, of course, is one of our most intimate interactions 
with the environment. Homeostasis is regulated by cellular 
and systemic mechanisms which, in turn, are dependent on 
gene-mediated responses. Genetic heterogeneity amongst 
people underlies the intrapopulation variability of the inter- 
action between nurture and nature. These generalizations 
apply equally to exposure to abnormal compounds and to 
excessive or inadequate exposure to normal components in 
the diet or environment. 
Homeostasis comprises several processes, some of which 
act synchronously, but many of which act in a specific 
sequence, each being triggered by the relative efficiency of 
the preceding process. Some of these mechanisms are 
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specific for individual compounds. This applies to essential 
nutrients or generic groups of nutrients, but for non-nutri- 
ents and xenobiotics there appears to be a limited number of 
common protective mechanisms. In the chain arising from 
threatened or actual toxic exposure there would first be 
compensatory adaptations such as metabolic biotransforma- 
tions (phase I: oxidation, hydrolysis, reduction; phase 11: 
conjugations), excretion, and sequestration of compounds 
(for example in adipose tissue, bone, hair, skin); when these 
are inadequate biochemical and histopathological features 
follow with structural cellular damage and functional 
derangement. These lead to tissue damage with clinical 
manifestations (e.g. neurological and muscular toxicity, 
retinal toxicity, immunotoxicity, hepatotoxicity, nephro- 
toxicity, bone marrow damage, teratogenicity, cytotoxicity, 
cancer, methaemoglobinaemia, haemolysis) and overt dis- 
ease states many of which are major health issues (e.g. 
cancers, cardiovascular disease, obesity, osteoporosis, 
adverse reactions to foods and food additives and contamin- 
ants, atopic disease, behavioural abnormalities, fetotoxic 
effects). This chain shows the series of genotypic (genetic), 
and phenotypic (biochemical and clinical) biomarkers. 
The underlying assumption here is that all diet-related 
disease arises from an inappropriate interaction between 
diet and systemic homeostasis and that the fundamental 
basis of this imbalance lies in the relative imbalance of 
dietary exposure and the genetic controlled response. At this 
level the genome and its product would serve as an ideal 
biomarker: unfortunately the processes involved might not 
have been identified or might not be accessible to practical 
and ethical sampling techniques. Alternative and less 
immediate biomarkers have to be used. However, the 
more remote the biomarker is from the primary event the 
more it is attenuated and subject to confounding factors. It 
becomes less specific. On the other hand the more immediate 
it is to the basic interaction the more quantitatively related 
and predictive it becomes: biomarkers represent Garrod’s 
concept that genetic factors determine the nature of chemical 
metabolism and human biochemical heterogeneity. 
More immediate biomarkers are not only potentially 
more predictive, they might also provide more immediate 
outcomes which could be used to assess interventions in a 
reasonable timescale and, in turn, replace the temporally 
and aetiologically remote outcomes which are so often the 
foci of epidemiological studies of diet and health: for 
example the diseases mentioned earlier are probably both 
metabolically and temporally remote from their aetiology. 
Insight into the metabolic processes involved in the parti- 
cular issue being investigated can inform the choice of tissue 
or fluid to be sampled and the phenotypic marker to be 
measured. This applies also to genotypic biomarkers designed 
to assess adaptive phenomena but it is possible to measure 
some predictive genotypic markers in tissues other than those 
in which the gene product is expressed. Whatever the situation 
the selection of biomarker(s) should be dictated by the 
problem being considered rather than by the accessibility of 
tissue or fluid to be measured or the ease of an assay. 
These general points are represented by the disease PKU 
which epitomizes the interaction between nature and nurture 
and the benefits which can be attained by an appropriate 
manipulation of the diet. PKU is a manifestation of HPA 
which results from the altered activity of the principally 
hepatic enzyme phenylalanine hydroxylase (EC 1.14.16.1; 
PAH), functional defects of which arise from intrinsic 
defects in the apoenzyme or from defective synthesis of 
its cofactor (tetrahydrobiopterin) (Scriver & Clow, 1980; 
Giittler, 1984; Scriver, 1991; Scriver et al. 1996; Giittler & 
Guldberg, 1996). The condition was recognized in 1933 
when a mother with a mentally retarded child sought help on 
the peculiar smell of her child’s urine. She saw several 
doctors, one of whom even referred her to a psychiatrist for 
help with her delusion. In the end one physician, Dr Asbjorn 
Folling confirmed the peculiar smell. He attributed it to the 
presence of phenylpyruvic acid in the urine and he called the 
condition ‘imbecillitas phenylpyruvica’ thereby incorporat- 
ing both the initial clinical and biochemical biomarkers into 
the condition’s nomenclature (Giittler, 1984; Scriver, 199 1). 
He developed the ‘FeC13’ colorimetric test of urine to detect 
the excess metabolite and used it to screen mentally retarded 
children and adults for the condition (Scriver & Clow, 
1980). In 1950 Horst Bickel appreciated the implication of 
raised blood phenylalanine concentrations in PKU patients 
and explored the use of a phenylalanine-free mixture of 
amino acids to feed affected infants. It was found that blood 
phenylalanine levels fell and that the urine abnormality 
decreased. There was also some clinical and behavioural 
improvement, but the intervention was too late to affect the 
established developmental delay and mental damage. 
Nonetheless this progress in the phenotypic biomarkers 
demonstrated the potential clinical and economic benefits 
of screening and early diagnosis in the hope that early 
dietary intervention could prevent the neurological damage. 
Early dietary management was effective, but many cases 
went undetected because the FeC13 biomarker was relatively 
insensitive and non-specific (Scriver & Clow, 1980). 
Phenylpyruvic acid is one of a number of normal metabol- 
ites of phenylalanine which are found in excessive amounts 
in the urine in PKU as a consequence of the increased 
activity of alternative pathways for the metabolism of 
phenylalanine. Other variables affected the production of 
these metabolites and it was appreciated that blood phenyl- 
alanine concentrations would be a better biomarker, but the 
analytical techniques (paper chromatography) available at 
that time were costly and time consuming. In the late 1950s 
the abnormal gene product, i.e. defective PAH, was identi- 
fied, but since this activity was in the liver this did not 
provide an effective biomarker. The finding of this func- 
tional defect reinforced the opinion that screening should be 
targeted at the HPA. 
Guthrie solved the problem in 1961 by establishing a 
semiquantitative bioassay based on the inhibition of bacter- 
ial growth by high concentrations of phenylalanine. The test 
was done on blood drops collected on filter card from infants 
at 4-7 d of age by which time the babies would have fed 
and, in contrast to in utero, would have had the opportunity 
to challenge the activity of their endogenous PAH with a 
phenylalanine load. The biomarker for definitive diagnosis 
and monitoring of management was direct quantitative 
measurement of blood phenylalanine concentrations. This 
enabled an appreciation that these concentrations could 
correlate with the efficiency of management and with 
behavioural and other clinical outcomes. However, not all 
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patients responded similarly or predictably. Amongst this 
heterogeneity was an atypical group with HPA which was, 
in the mid 1970s, found to be secondary to a defect in the 
synthesis of the tetrahydrobiopterin cofactor. Thus, in the 
midst of the phenotypic and molecular heterogeneity which 
was becoming increasingly obvious, it was realized that 
PKU or HPA was not the result of a single gene defect. The 
allele for PAH has since been found on chromosome 12q, 
and that for the affected stage in tetrahydrobiopterin synth- 
esis is on chromosome 4 (Guttler & Guldberg, 1996; Scriver 
et al. 1996). 
HPA is, thus, evident as a complex entity with many 
clinical and metabolic phenotypes. Consistent with this 
heterogeneity and with the variation in dietary tolerance for 
phenylalanine, almost 300 mutations in the PAH gene have 
been identified. Some of these genetic mutations have been 
specifically correlated with the activity of their enzyme 
products and with the severity of the clinical disease (Scriver, 
1991; Guttler & Guldberg, 1996; Scriver et al. 1996). 
In the context of biomarkers, HPA represents a con- 
tinuum of genotypic, biochemical (PAH, tetrahydrobiopterin 
defect), metabolic (HPA), and clinical (the PKU syndrome) 
phenotypic biomarkers of an abnormal interaction between a 
dietary component and an individual’s ability to achieve 
effective homeostasis at customary dietary exposure. 
The genotypic biomarker may be used for definitive 
diagnosis and family screening and possibly for 
prognostication, but the metabolic biomarker is most 
useful for monitoring and tailoring the dietary reduction 
of phenylalanine. The urinary biomarker (PKU) is no longer 
of much use, and the clinical phenotypic biomarker is one of 
a medical tragedy. 
PKU and HPA demonstrate the movement of biomarkers 
from remote and non-specific outcomes (many other condi- 
tions including other inborn errors of metabolism cause 
epilepsy and developmental delay) to more specific and 
informative outcomes, and ultimately to the basic genomic 
mutation offering the opportunity of appropriately designed 
diets. It is feasible that in due course a similar heterogeneity 
will be found in the metabolism of other nutrients, and that 
this will explain many of the conflicting phenomena found in 
epidemiological studies of the interaction between diet and 
health and in apparent heterogeneity of nutritional require- 
ments. Such biomarkers should also provide more definitive 
indicators of response to interventions, thereby enabling 
shorter and more definitive epidemiological studies. Whether 
or not people would accept the corollary of this, namely 
specific diets tailored to their genotypic or surrogate meta- 
bolic characteristics, depends probably on the nature of the 
diets involved and on the people’s motivation in the context 
of the much less dramatic and immediate effects of an 
inappropriate diet compared with that experienced with 
PKU. The integration of markers of susceptibility with 
appropriate follow up of long-term outcomes by epidemio- 
logical studies of characterized populations will demonstrate 
the relevance or otherwise of formal interventions. 
12. Conclusions 
Food supply and the metabolism of food ingredients in 
women during pregnancy and lactation and in their children 
have implications for long-term health and child develop- 
ment. Epidemiological evidence and studies performed in 
infants have highlighted the fact that maternal and intra- 
uterine influences are of special importance during the 
development of the infant and child. Early nutrition 
modulates growth and functional development of the organ- 
ism and appears to exert life-long programming effects that 
modulate health, disease and mortality risks in adulthood, 
neural function and behaviour, and quality of life. 
The field of nutrient-gene interaction is in a phase of 
rapid expansion and development. There are several areas 
where dietary modulation of gene expression could exert 
beneficial effects, for example with respect to lipid metab- 
olism and risk of cardiovascular disease. Applied research 
should further elucidate the interaction of nutrients and gene 
expression. The genes affected by specific nutrients, e.g. 
amino acids, must be characterized in animal models as well 
as the underlying cellular and molecular mechanisms. Since 
the vast majority of studies have been performed on animal 
models or animal cell lines, strategies must be defined to 
approach these questions in human subjects, for example by 
using human cell lines responding to nutrients. Once the 
mechanisms and relevance to man have been clarified, then 
development and testing of existing or new ‘functional 
foods’ could be performed both in animals and human 
subjects. 
The relation between nutrients and differentiation needs 
to be further explored by in vivo models, studying food 
effects on cell differentiation and later performance. Con- 
comitantly, the effects of nutrients on cell differentiation in 
in vitro studies should be strongly encouraged. 
The course of pregnancy, childbirth and lactation as well 
as human milk composition and the short- and long-term 
outcome of the child may be influenced by the intake of 
foods and particularly micronutrients, e.g. PUFA, Fe, Zn 
and I. Folic acid supplementation from before conception 
through the first weeks of pregnancy was reported to 
markedly reduce the occurrence rates of severe embryonic 
malformations, including anencephaly and spina bifida. The 
potential of exerting beneficial effects for mother and child 
by modulating maternal nutrient supply should be further 
explored. 
The evaluation of dietary effects on child growth requires 
epidemiological and field studies as well as evaluation of 
specific cell and tissue growth. Novel substrates, growth 
factors and conditionally essential nutrients (e.g. growth 
factors, amino acids, unsaturated fatty acids) may be poten- 
tially useful as ingredients in functional foods and need to 
be assessed carefully with respect to their potential effects 
on growth, maturation and development of specific cell 
types, tissues and organs under different physiological 
conditions. In particular, the potential modulation of later 
obesity by early food choices needs to be further explored. 
Intestinal growth, maturation, intestinal adaptation and 
regulation and long-term function may be influenced by 
food ingredients. The roles of compounds such as dietary 
oligosaccharides, gangliosides, high-molecular-mass glyco- 
proteins, bile salt-activated lipase, pre- and probiotics as to 
their physiological functions in the developing organism 
need to be further explored. The interaction of the appro- 
priate genes of intestinal substrate transporters and their 
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substrates in early childhood is not well understood and 
needs to be clarified. 
There are indications for some beneficial effects of 
functional foods on the developing immune response in 
vitro and in vivo, for example induced by antioxidant 
vitamins, trace elements, fatty acids, arginine, nucleotides, 
and altered antigen content in infant foods. A general 
unresolved issue is related to the lack of reliable surrogate 
outcome markers when investigating the effects of nutrition 
on the developing immune response and possible long-term 
benefits. 
Peak bone mass at the end of adolescence can be 
increased by dietary means, which is expected to be of 
long-term importance for the prevention of osteoporosis at 
older ages. Future studies should be directed to the com- 
bined effects of Ca and other constituents of growing bone, 
such as P, Mg and Zn, as well as vitamins D and K, and trace 
elements F and B. In addition to observational and inter- 
vention studies, in vitro and animal model studies might 
provide a basis for new concepts on the interaction and 
optimal relative proportions of the several macro- and 
micronutrients involved in bone growth and mineralization. 
Pregnancy and the first postnatal months are critical time 
periods for the growth and development of the human 
nervous system, processes for which adequate substrate 
supplies are essential. Early diet may have long-term effects 
on the structure and function of the nervous system, sensory 
and cognitive abilities as well as behaviour. The potential 
beneficial effects of a balanced supply of nutrients such as I, 
Fe, Zn and PUFA need to be explored in further detail. 
The question of a possible relationship between early 
exposure to tastes and flavours and later food choice pref- 
erences may have a major impact on public health and needs 
to be further elucidated. 
Bioactive factors such as human milk proteins, peptides, 
growth factors and other substances may be produced for 
use in food products with the use of biotechnology and 
recombinant techniques. The inclusion of such substances 
into dietary products may have beneficial physiological 
effects particularly in infancy and early childhood, for 
example defence against infectious agents, the optimization 
of nutrient uptake from the diet as well as the differentiation 
and growth of cells and tissues. The enormous potential of 
these methodologies for improving food products needs to 
be further explored. 
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